<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2024.1465126</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>&#x201c;Dictionary of immune responses&#x201d; reveals the critical role of monocytes and the core target IRF7 in intervertebral disc degeneration</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Xu</surname>
<given-names>Peichuan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2388301"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Kaihui</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yuan</surname>
<given-names>Jinghong</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/974494"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhao</surname>
<given-names>Jiangminghao</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2298729"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pan</surname>
<given-names>Huajun</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pan</surname>
<given-names>Chongzhi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1459432"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xiong</surname>
<given-names>Wei</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1058038"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tan</surname>
<given-names>Jianye</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/943574"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Tao</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1897263"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Huang</surname>
<given-names>Guanfeng</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Xiaolong</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Miao</surname>
<given-names>Xinxin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>He</surname>
<given-names>Dingwen</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Cheng</surname>
<given-names>Xigao</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1378651"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Orthopaedics, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University</institution>, <addr-line>Nanchang</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Jiangxi Provincial Key Laboratory of Spine and Spinal Cord Disease, Nanchang University</institution>, <addr-line>Nanchang</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Stomatology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University</institution>, <addr-line>Nanchang</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Sadiq Umar, University of Illinois Chicago, United States</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Ren&#xe9; Huber, Hannover Medical School, Germany</p>
<p>Weihang Li, Fourth Military Medical University, China</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Xigao Cheng, <email xlink:href="mailto:xigaocheng@hotmail.com">xigaocheng@hotmail.com</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>17</day>
<month>10</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1465126</elocation-id>
<history>
<date date-type="received">
<day>15</day>
<month>07</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>25</day>
<month>09</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Xu, Li, Yuan, Zhao, Pan, Pan, Xiong, Tan, Li, Huang, Chen, Miao, He and Cheng</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Xu, Li, Yuan, Zhao, Pan, Pan, Xiong, Tan, Li, Huang, Chen, Miao, He and Cheng</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>Intervertebral disc degeneration (IDD) is widely regarded as the primary contributor to low back pain(LBP). As an immune-privileged organ, upon the onset of IDD, various components of the nucleus pulposus (NP) are exposed to the host&#x2019;s immune system, accumulating cytokines. Cytokines facilitate intercellular communication within the immune system, induce immune cells polarisation, and exacerbate oxidative stress in IDD. </p>
</sec>
<sec>
<title>Methods</title>
<p>Machine learning was used to identify crucial immune cells. Subsequently, Immune Response Enrichment Analysis (IREA) was conducted on the key immune cells to determine their cytokine responses and polarisation states in IDD. &#x201c;CellChat&#x201d; package facilitated the analysis of cell-cell communication. Differential gene expression analysis, PPI network, GO and KEGG pathway enrichment analysis, GSVA, co-expressed gene analysis and key gene-related networks were also performed to explore hub genes and their associated functions. Lastly, the differential expression and functions of key genes were validated through <italic>in vitro</italic> and <italic>in vivo</italic> experiments.</p>
</sec>
<sec>
<title>Results</title>
<p>Through multiple machine learning methods, monocytes were identified as the crucial immune cells in IDD, exhibiting significant differentiation capacity. IREA revealed that monocytes in IDD polarize into an IFN-a1 and IFN-b enriched Mono-a state, potentially intensifying inflammation. Cell&#x2013;cell communication analysis uncovered alteration in ANNEXIN pathway and a reduction in CXCL signaling between macrophages and monocytes, suggesting immune response dysregulation. Furthermore, ten algorithms identified three hub genes. Both experiments conducted <italic>in vitro</italic> and <italic>in vivo</italic> have conclusively shown that IRF7 serves as a crucial target for the treatment of IDD, and its knockdown alleviates IDD. Eight small-molecule drugs were predicted to have therapeutic potential for IDD.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>These findings offer a multidimensional understanding of the pathogenesis of IDD, pinpointing monocytes and key genes as potential diagnostic and therapeutic targets. They provide novel insights into potential diagnostic and therapeutic targets for IDD.</p>
</sec>
</abstract>
<kwd-group>
<kwd>intervertebral disc degeneration</kwd>
<kwd>cytokine</kwd>
<kwd>monocytes</kwd>
<kwd>machine learning</kwd>
<kwd>single-cell sequencing</kwd>
<kwd>IRF7</kwd>
</kwd-group>
<contract-num rid="cn001">82060403</contract-num>
<contract-sponsor id="cn001">Natural Science Foundation of Jiangxi Province<named-content content-type="fundref-id">10.13039/501100004479</named-content>
</contract-sponsor>
<counts>
<fig-count count="15"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="75"/>
<page-count count="23"/>
<word-count count="8044"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Inflammation</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>Intervertebral disc degeneration (IDD), a prevalent degenerative condition, predominantly impacts middle-aged and elderly individuals, often resulting in chronic low back pain (LBP) (<xref ref-type="bibr" rid="B1">1</xref>). LBP affects an estimated 80% of the world&#x2019;s population, significantly diminishing their quality of life and imposing a substantial economic toll on society (<xref ref-type="bibr" rid="B2">2</xref>). The intervertebral disc, situated between two adjacent vertebrae, comprises the annulus fibrosus (AF), nucleus pulposus (NP), and cartilaginous endplate (CEP) located above and below the vertebrae (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B4">4</xref>). The NP, a gelatinous core, primarily comprises water, proteoglycans, and collagen. It withstands and distributes pressure while maintaining the height and hydration of the intervertebral disc through its high osmotic pressure properties (<xref ref-type="bibr" rid="B5">5</xref>).</p>
<p>During disc degeneration, the NP&#x2019;s ability to synthesize proteoglycans and collagen decreases, leading to reduced moisture content and impaired pressure resistance. At the same time, there is an increased expression of inflammatory mediators and proteases within the NP, which degrade the extracellular matrix (ECM), further compromising the structural integrity of the disc (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>). These biochemical changes can also trigger or exacerbate the inflammatory response, creating a vicious cycle that accelerates disc degeneration (<xref ref-type="bibr" rid="B8">8</xref>). Thus, it is essential to explore the pathological mechanisms of IDD and identify targets for nucleus pulposus cells (NPCs) dysfunction to develop effective diagnostic and therapeutic strategies for IDD.</p>
<p>Since its formation, the NP has been encapsulated by the AF and the CEP, creating a unique structure that isolates the NP from the host&#x2019;s immune system. Thus, the intervertebral disc is recognized as an immune-privileged organ (<xref ref-type="bibr" rid="B9">9</xref>). During IDD, various components of the NP can elicit an autoimmune response upon exposure to the host&#x2019;s immune system, resulting in vascular infiltration and the aggregation of inflammatory cytokines that disrupt the homeostasis of the disc (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>).</p>
<p>Cytokines, a wide range of small secreted proteins, bind to homologous receptors on target cells, mediate intercellular communication within the immune system, and are essential therapeutic targets (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>). Natural disc cells produce numerous cytokines up-regulated during IDD, driving many metabolic processes of disc degeneration (<xref ref-type="bibr" rid="B14">14</xref>&#x2013;<xref ref-type="bibr" rid="B16">16</xref>). Phillips et&#xa0;al. have shown that NPCs produce multiple cytokines and chemokine receptors and can exhibit paracrine and autocrine response modes (<xref ref-type="bibr" rid="B17">17</xref>). These cytokines further promote IDD progression by activating intracellular signaling pathways (<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>). During IDD progression, these cytokines may up-regulate neurotrophic and angiogenic factors, leading to angiogenesis and innervation (<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B21">21</xref>). Thus, the role of cytokines in the progression of IDD cannot be ignored. Cytokine-based therapies and antagonists treat various diseases, including cancer and autoimmune diseases (<xref ref-type="bibr" rid="B22">22</xref>). Numerous studies have highlighted the central role of cytokines in immunity. However, previous studies have often lacked a comprehensive view of each immune cell type for each cytokine. Ang Cui et&#xa0;al. mapped the global view of &#x201c;immune-cytokine&#x201d; correspondences on a single-cell scale, creating a &#x201c;Dictionary of immune responses&#x201d; (<xref ref-type="bibr" rid="B22">22</xref>). This &#x201c;dictionary&#x201d; can identify the most active cytokines in disease and how different immune cells perform different functions depending on the cytokine signals they receive. Its emergence provides a new perspective for studying cytokine-immune cell polarisation in diseases and helps better understand the roles of immune cells in disease development.</p>
<p>In this study, a multifaceted bioinformatics approach was employed to explore the role of cytokine-driven monocytes polarisation in the immune system and identify essential genes that could impact the disease, suggesting potential therapeutic targets for alleviating IDD.</p>
</sec>
<sec id="s2">
<label>2</label>
<title>Methods</title>
<sec id="s2_1">
<label>2.1</label>
<title>Transcriptome data sources</title>
<p>The flowchart depicted in <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref> outlines the systematic approach undertaken in this study. All datasets employed for this research are accessible to the public, ensuring transparency and reproducibility. The transcriptome data were sourced from the publicly accessible Gene Expression Omnibus (GEO) database at <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/">https://www.ncbi.nlm.nih.gov/geo/</ext-link>. High-throughput sequencing data from GSE176205 and GSE167199 were corrected for batch effects using the &#x201c;sva&#x201d; package(version 3.42.0) in R (<xref ref-type="bibr" rid="B23">23</xref>). The sequencing platform for GSE176205 was GPL20301 Illumina HiSeq 4000 (Homo sapiens), which included 6 IDD and 3 standard control NP samples. The sequencing platform for GSE167199 was GPL24676 Illumina NovaSeq 6000 (Homo sapiens), including 3 IDD and 3 standard control NP samples. GSE167931 was utilized as an additional dataset for validation purposes, sequenced on the GPL20795 HiSeq X Ten (Homo sapiens) platform, and included 5 IDD and 4 standard control NP samples.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Flowchart of this study.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1465126-g001.tif"/>
</fig>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Download and processing of single-cell sequencing data</title>
<p>A single-cell sequencing dataset was retrieved from the GEO database, which contained 16 samples (8 IDD and 8 standard control NP samples). The &#x201c;Seurat&#x201d; R package(version 4.2.0) was employed in the R to import the raw data within GSE153066 from the database (<xref ref-type="bibr" rid="B24">24</xref>). Filtering out low-quality cells and genes involved applying stringent criteria to ensure data quality: 1) Cells that failed to express at least 200 genes were excluded. 2) Cells with a mitochondrial gene expression percentage below 25% were also retained. 3) Cells with fewer than 4,000 expressed genes were retained. 4) Cells with a UMI reading of fewer than 10,000 were retained. The data were normalized using the &#x201c;Seurat&#x201d; R package. Following normalization, balancing average expression and dispersion was employed to pinpoint highly variable genes. Principal component analysis (PCA) yielded significant PCs, which served as input for graph-based clustering. A harmony approach was used to eliminate batch effects across samples. For clustering, the &#x201c;FindClusters&#x201d; function, leveraging the optimized Shared Nearest Neighbor (SNN) modular clustering algorithm, was applied to identify 16 distinct clusters with a resolution of 0.5. The &#x201c;RunUMAP&#x201d; function was used for Uniform Manifold Approximation and Projection (UMAP). UMAP-1 and UMAP-2 visualized cell aggregation, subsequently enabling the identification of cell clusters based on their type-specific biomarkers. The &#x201c;RunTSNE&#x201d; function was then used for t-distributed stochastic neighbour embedding(t-SNE). t-SNE-1 and t-SNE-2 visualized T cell aggregation.</p>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>Single sample gene set enrichment analysis (ssGSEA)</title>
<p>ssGSEA represents an extension of Gene Set Enrichment Analysis(GSEA) and it was employed to calculate enrichment scores for each cell type in conventional transcriptome data based on a list of marker genes (<xref ref-type="bibr" rid="B25">25</xref>). Based on a list of marker genes for each cell type, we used &#x201c;GSVA&#x201d; R package (version 1.42.0) to perform ssGSEA analysis to calculate the enrichment fraction of each cell type in transcriptome data.</p>
</sec>
<sec id="s2_4">
<label>2.4</label>
<title>Machine learning</title>
<p>Support Vector Machine-Recursive Feature Elimination (SVM-RFE), a machine learning approach, trains subsets of features across categories to refine the set and pinpoint the most predictive genes. Utilizing the &#x201c;glmnet&#x201d; package in R (version 4.1.4), LASSO regression was implemented to compute and select linear models, effectively retaining only informative variables. Random forest analysis was conducted using the &#x201c;RandomForest&#x201d; function, where the minimum error was chosen as the mtry node value, and the stabilized image value was selected as the ntree. The results of SVM-RFE, LASSO regression, and Random forest were combined to select the key immune cells in this study.</p>
</sec>
<sec id="s2_5">
<label>2.5</label>
<title>Immune response enrichment analysis</title>
<p>Immune Response Enrichment Analysis (IREA) is a method Ang Cui et&#xa0;al. proposed to infer cytokine activity and immune cell polarisation during immunization (<xref ref-type="bibr" rid="B26">26</xref>). In a cell type-centric view, IREA uncovers over 66 distinct cytokine-mediated polarisation states within immune cell types, encompassing novel and previously undescribed states. IREA was used to calculate the cytokines that primarily generate a response based on the differentially expressed genes (DEGs) of vital immune cells and the polarisation states of critical immune cells in IDD.</p>
</sec>
<sec id="s2_6">
<label>2.6</label>
<title>Cell-cell communication analysis and ligand-receptor expression</title>
<p>Using the &#x201c;CellChat&#x201d; (version 1.1.3) R package, CellChat objects were constructed (<xref ref-type="bibr" rid="B27">27</xref>). Cell-cell communication was analyzed using the &#x201c;CellChatDB.human&#x201d; ligand-receptor interaction database as the reference. The &#x201c;mergeCellChat&#x201d; function was employed to combine the CellChat objects of each group, enabling a comparison of the interaction number and the interaction strength. The &#x201c;netVisual_diffInteraction&#x201d; function was used to visualize differences in the number or strength of interactions between groups and different cell types. Finally, the &#x201c;netVisual_aggregate&#x201d; function was used for visualization.</p>
</sec>
<sec id="s2_7">
<label>2.7</label>
<title>Identification of differentially expressed genes</title>
<p>The DEGs were identified utilizing the &#x201c;limma&#x201d; R package (version 3.50.0) (<xref ref-type="bibr" rid="B28">28</xref>). The screening criteria were |log2Fold Change|&gt;1 and adjusted p-value &lt;0.05. Heatmaps were created employing the &#x201c;pheatmap&#x201d; R package(version 1.0.12) and clustered using euclidean distance and hierarchical clustering methods. Further, we explored the differences between the two groups in single-cell data. The &#x201c;FindAllMarkers&#x201d; function in the &#x201c;Seurat&#x201d; R package was employed to identify DEGs of vital immune cells between two groups.</p>
</sec>
<sec id="s2_8">
<label>2.8</label>
<title>Protein-protein interaction network construction</title>
<p>A PPI network was constructed by utilizing the Search Tool for the Retrieval of Interacting Genes (STRING) online resource (<xref ref-type="bibr" rid="B29">29</xref>). Sub-networks were constructed for proteins with interaction scores greater than 700, from which proteins with direct interactions with intersecting DEGs were extracted and analyzed. Afterward, PPI network analysis was executed using the Cytohubba plug-in (<xref ref-type="bibr" rid="B30">30</xref>). Ten algorithms (Betweenness, BottleNeck, Closeness, Degree, EcCentricity, EPC, MCC, MNC, Radiality and Stress) were used to screen the top 100 proteins in terms of importance. The intersecting proteins from these algorithms and the genes identified in the intersecting DEGs were designated as key genes.</p>
</sec>
<sec id="s2_9">
<label>2.9</label>
<title>Gene ontology (GO) and kyoto encyclopedia of genes and genomes(KEGG) pathway enrichment analysis</title>
<p>GO enrichment analysis includes three domains: biological process (BP), molecular function (MF), and cellular component (CC) analysis (<xref ref-type="bibr" rid="B31">31</xref>). The KEGG is a bioinformatics resource for identifying enriched and significantly altered metabolic pathways within gene lists (<xref ref-type="bibr" rid="B32">32</xref>). The genes of interest in IDD were analyzed for GO and KEGG enrichment using the R package &#x201c;clusterProfiler&#x201d; (version 4.2.2) (<xref ref-type="bibr" rid="B33">33</xref>).</p>
</sec>
<sec id="s2_10">
<label>2.10</label>
<title>GeneMANIA</title>
<p>The GeneMANIA website (<ext-link ext-link-type="uri" xlink:href="http://genemania.org">http://genemania.org</ext-link>) forecasts associations between functionally analogous genes and pivotal genes (<xref ref-type="bibr" rid="B34">34</xref>). Gene interaction networks for key genes were constructed using the GeneMANIA website.</p>
</sec>
<sec id="s2_11">
<label>2.11</label>
<title>Gene set variation analysis (GSVA)</title>
<p>To explore the disparities in biological functionalities between the two groups, the gene set &#x201c;h.all.v2023.1.Hs.symbols.gmt&#x201d; sourced from the MSigDB was employed as the reference gene set. GSVA was performed using the R package &#x201c;GSVA&#x201d; (version 1.42.0).</p>
</sec>
<sec id="s2_12">
<label>2.12</label>
<title>Construction of ceRNA network, RBP-mRNA network, mRNA-TF network</title>
<p>Since the mechanism of action of competing endogenous RNA (ceRNA) in IDD remains unclear, we used miRTarBase (<ext-link ext-link-type="uri" xlink:href="https://mirtarbase.cuhk.edu.cn/~miRTarBase/miRTarBase_2022/php/index.php">https://mirtarbase.cuhk.edu.cn/~miRTarBase/miRTarBase_2022/php/index.php</ext-link>), starbase3.0 (<ext-link ext-link-type="uri" xlink:href="https://rnasysu.com/encori">https://rnasysu.com/encori</ext-link>) and miRDB databases (<ext-link ext-link-type="uri" xlink:href="https://mirdb.org/index.html">https://mirdb.org/index.html</ext-link>) to back-predict microRNAs of key genes and to predict lncRNAs of common microRNAs of key genes, constructing a ceRNA network (<xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B36">36</xref>).</p>
<p>The open-source platform (<ext-link ext-link-type="uri" xlink:href="https://starbase.sysu.edu.cn/tutorialAPI.php#RBPTarget">https://starbase.sysu.edu.cn/tutorialAPI.php#RBPTarget</ext-link>) was used to investigate mRNA and RNA-binding protein (RBP) expression associations.</p>
<p>The mRNA-TF interaction relationships between key genes were constructed using the TRRUST(Transcriptional Regulatory Relationships Unraveled by Sentence-based Text Minmining) database. Networks were constructed using Cytoscape(version 3.9.1).</p>
</sec>
<sec id="s2_13">
<label>2.13</label>
<title>Cell culture and processing</title>
<p>We acquired human NPCs from Procell Life Science &amp; Technology Co., Ltd (CP-H097, Wuhan, China). We cultured in F12/DMEM medium (Gibco, USA) supplemented with 1% Penicillin-Streptomycin Solution (NCM Biotech, China) and 10% fetal bovine serum (FBS; Gibco, USA). As described in previous literature, NPCs were induced using 100 &#xb5;M TBHP (Sigma-Aldrich, St. Louis, MO, USA) for 4 hours to construct the IDD model <italic>in vitro</italic> (<xref ref-type="bibr" rid="B37">37</xref>). Cells were transfected with small interfering RNA (si-RNA) to knock down IRF7 (ENSG00000185507, Gene ID: 3665) using the riboFECT CP Transfection Kit (RiboBio, Cat. No C10511-05, China).</p>
</sec>
<sec id="s2_14">
<label>2.14</label>
<title>RNA extraction and PCR</title>
<p>Total RNA was extracted from the cells using TRIzol (Thermo Fisher, USA) and chloroform (Thermo
Fisher, USA). The purity and concentration of RNA samples were quantitatively assessed utilizing a Nanodrop One spectrophotometer (Thermo Fisher, USA). cDNA synthesis from the extracted RNA was performed using the PrimeScript RT reagent. Reverse transcription reagents were purchased from TaKaRa, and an RT-qPCR assay was conducted using an ABI 7500 Real-Time PCR machine (Thermo Fisher, USA). <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1</bold>
</xref> provides the primer sequences employed in the study.</p>
</sec>
<sec id="s2_15">
<label>2.15</label>
<title>Animal model</title>
<p>The Ethics Committee of Nanchang University approved all experimental procedures involving animals, and all procedures followed the ARRIVE guidelines. Male Sprague-Dawley (SD) rats, aged 12 weeks, were sourced from SpePharm Biotechnology Ltd. (Beijing, China). A rat tail puncture model was established according to the protocol described in the literature (<xref ref-type="bibr" rid="B38">38</xref>). Rats were administered 4% sodium pentobarbital (1mL/1kg) to induce anaesthesia. Following skin sterilization, a 21-gauge needle was employed to make a vertical puncture into the Co4/5 disc of the tail, reaching a depth of approximately 5 millimeters. Upon completing the puncture, the needle was rotated in a full 360-degree motion and maintained in position for one minute. On postoperative days 1, 7, and 14, si-RNA and control agent si-NC 5 nmol (10 &#xb5;L) were delivered directly into the disc along the original puncture channel. The health status of the rats was monitored daily after surgery. The flowchart of the animal experiment was performed by Figdraw (<ext-link ext-link-type="uri" xlink:href="http://www.figdraw.com">www.figdraw.com</ext-link>).</p>
</sec>
<sec id="s2_16">
<label>2.16</label>
<title>X-ray and magnetic resonance imaging (MRI)</title>
<p>X-rays and MRIs of the caudal intervertebral discs of rats were performed at 4 weeks postoperatively. The disc height index (DHI) score was utilized to quantify the structural integrity of the discs. This score was derived from the ratio of the intervertebral space height to the height of the neighbouring vertebral bodies observed in X-ray images. Additionally, the severity of IDD was assessed using MRI images and analyzed with the Pfirrmann grading system as a standardized reference.</p>
</sec>
<sec id="s2_17">
<label>2.17</label>
<title>HE and SO&amp;FG staining</title>
<p>4 weeks post-surgery, the rats were euthanized, and their disc samples were fixed and immersed in 4% paraformaldehyde. Following the EDTA decalcification solution, the disc samples were dehydrated, embedded in paraffin, and sectioned serially. NP morphology was examined using hematoxylin-eosin (HE) and Safranin O-Fast Green (SO&amp;FG) staining.</p>
</sec>
<sec id="s2_18">
<label>2.18</label>
<title>Immunohistochemical staining</title>
<p>Sections were treated with a 3% hydrogen peroxide solution to block endogenous peroxidase activity, followed by 3% bovine serum albumin (BSA; Servicebio, Cat no: GC305010). Primary antibodies used were COL2A1(Proteintech,Cat No.28459-1-AP), MMP13(Proteintech,Cat No.18165-1-AP), NLRP3(Proteintech,Cat No. 19771-1-AP) and IL-1&#x3b2;(Proteintech,Cat No. 16806-1-AP). These were incubated overnight at a temperature of 4&#xb0;C. HRP-coupled secondary antibodies (Servicebio, Cat no: GB23303) were then used for the corresponding primary antibodies. Finally, the samples were stained using diaminobenzidine and hematoxylin to label the nucleus.</p>
</sec>
<sec id="s2_19">
<label>2.19</label>
<title>Immunofluorescence</title>
<p>The NPCs were fixed with 4% Paraformaldehyde Fix Solution (Biosharp, China, Cat no: BL539A) for 15 minutes. The cells were blocked with 3% BSA at room temperature for 30 minutes. Then, the cells were incubated overnight with antibodies against COL2A1, MMP13,NLRP3 and IL-1&#x3b2;. After washing the samples, the secondary antibody was added and incubated at room temperature for 50 minutes (Servicebio, Cat no:GB21303). The samples were rewashed, and DAPI staining solution was added for incubation at room temperature in the dark for 10 minutes.</p>
</sec>
<sec id="s2_20">
<label>2.20</label>
<title>Small molecule drug prediction and molecular docking</title>
<p>Based on the top 20 up-regulated and 20 down-regulated genes with significant differences between the IDD group and the control group, small molecule compounds that might be effective in treating IDD were predicted using the Connectivity Map (CMAP) database. Eight compounds with the highest scores as potential drugs were selected, with toxic compounds excluded. We downloaded SDF format files for potential drugs from PubChem, PDB files of target proteins in the PDB database, and dehydrated and deliganded the proteins in PyMOL. Proteins were hydrogenated in AutoDockTools (version 1.5.7). Molecular docking was then performed in AutoDockTools. The strength of the binding energy serves as an indicator of the probability of the receptor and ligand binding together, with a decrease in binding energy corresponding to an increase in the affinity. The lower the binding energy, the more stable the conformation of the receptor became. The results of molecular docking were visualized in PyMOL.</p>
</sec>
<sec id="s2_21">
<label>2.21</label>
<title>Statistical analysis</title>
<p>Statistical analyses were performed utilizing R software (version 4.1.2). Spearman&#x2019;s correlation test were employed to examine associations between two variables. The Wilcoxon rank-sum test was applied for comparisons between two groups, while the Kruskal-Wallis test was utilized for comparisons involving three or more groups. A statistical significance threshold was set at a p-value of less than 0.05.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="s3_1">
<label>3.1</label>
<title>Single-cell dimensionality reduction clustering and annotation</title>
<p>After initial quality control and doublet removal of IDD and control samples, 65,165 cells were obtained from the single-cell dataset. All cells were aggregated into 16 clusters (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>). And annotated by cell-specific biomarkers, we finally found 9 cell types, namely: nucleus pulposus (NP, cluster 0,1,4,5,14), progenitor nucleus pulposus (Pro_NP, cluster 2, 11), Monocyte (cluster 3,6,15), Macrophage (cluster 7), Neutrophil (cluster 8), T cell (cluster 9), Erythrocyte (cluster 10), B cell (cluster 12), and Endothelial cell (cluster 13) (<xref ref-type="fig" rid="f2">
<bold>Figures&#xa0;2B, C</bold>
</xref>). The distribution and number of different cell types varied significantly between the two groups (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2D</bold>
</xref>). NPCs were most reduced considerably in the IDD group, while Pro_NP, Macrophage, Erythrocyte, B cell, and Endothelial cell were also reduced to varying degrees. Monocytes increased most significantly in the IDD group, and Neutrophil also increased in IDD. T cells were re-clustered and categorized into CD4<sup>+</sup> T cells and CD8<sup>+</sup> T cells based on their distinct expression patterns (<xref ref-type="fig" rid="f2">
<bold>Figures&#xa0;2E&#x2013;H</bold>
</xref>).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Identification of cell types from single-cell sequencing data. <bold>(A)</bold> The UMAP plot illustrates the clustering of all cells into 16 distinct clusters. <bold>(B)</bold> Another UMAP plot shows the annotation of these 16 clusters into 9 different cell types. <bold>(C)</bold> The annotation reference plot displays the expression of marker genes for each cell type. <bold>(D)</bold> A bar chart presents the proportion of different cell types in the IDD and control groups. <bold>(E)</bold> t-SNE plot showing the re-clustering results and distribution of T cells. <bold>(F)</bold> Distribution of CD8 in T cells. <bold>(G)</bold> Distribution of CD4 in T cells. <bold>(H)</bold> t-SNE plot demonstrating the annotation results of T cell subsets.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1465126-g002.tif"/>
</fig>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>Screening of vital immune cells</title>
<p>The ssGSEA algorithm was used to calculate the enrichment scores of each cell type (<xref
ref-type="supplementary-material" rid="SM2">
<bold>Supplementary Table&#xa0;2</bold>
</xref>). There was a notable decrease in the number of macrophages in the IDD group compared to the control group. In contrast, the IDD group&#x2019;s monocytes count was significantly elevated compared to the control group. This is consistent with trends observed in the single-cell data (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>). The Random Forest, LASSO regression, and SVM-RFE were used to screen for critical immune cells. We selected the top 3 immune cells using the random forest algorithm based on Mean decrease accuracy (MDA ) and Mean decrease Gini (MDG), which were macrophages, monocytes, and neutrophils (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>). By LASSO regression analysis, we obtained the same three types of immune cells (<xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3C, D</bold>
</xref>). However, through the SVM-RFE method, we only screened for monocytes (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3E</bold>
</xref>). Finally, the immune cells detected by each method were intersected, concluding that the most critical immune cell in IDD was the monocytes (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3F</bold>
</xref>). The ROC curve showed that the monocytes enrichment score had good efficacy for distinguishing IDD samples from normal control samples (AUC=0.8333, <xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3G</bold>
</xref>).</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Screening of key immune cells via machine learning. <bold>(A)</bold> Box plot showing differences in cell enrichment scores between IDD and standard control samples. <bold>(B)</bold> The random forest analysis presents the ranking of the importance of six immune cell types in IDD from highest to lowest, Left: MDA; Right: MDG. <bold>(C)</bold> The coefficient distribution curve of each immune cell in the LASSO regression model. <bold>(D)</bold> Mean Squared Error in the LASSO regression model. <bold>(E)</bold> Error rate distribution in the SVM-RFE model. <bold>(F)</bold> The Venn diagram illustrates the identification of monocytes as key immune cells by three different machine learning algorithms. <bold>(G)</bold> The ROC curve confirms the critical role of monocytes in IDD.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1465126-g003.tif"/>
</fig>
</sec>
<sec id="s3_3">
<label>3.3</label>
<title>Immune response enrichment analysis of key immune cells</title>
<p>In order to clarify the changes of cytokines in monocytes during IDD and to explore the polarization state of monocytes after receiving different cytokines, we performed a comparative analysis of monocytes between different groups to explore the immune status of monocytes in IDD (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM3">
<bold>Supplementary Table&#xa0;3</bold>
</xref>). Subsequently, IREA was conducted based on significantly up-regulated differentially expressed genes in IDD. The cytokine enrichment plot showed that monocytes in IDD were predominantly enriched for cytokines such as IFN-a1 and IFN-b (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4B</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM4">
<bold>Supplementary Table&#xa0;4</bold>
</xref>). The cellular polarisation radar plot indicated that monocytes were primarily in the Mono-a polarisation state (type I interferon-induced polarisation), which may exacerbate the IDD&#x2019;s inflammatory response (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4C</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM5">
<bold>Supplementary Table&#xa0;5</bold>
</xref>). When IDD occurs, IFN-a1 and IFN-b are significantly enriched in the intervertebral disc. And the monocytes are in a Mono-a polarized state, which may lead to the aggregation of inflammatory factors and matrix degradation in the intervertebral disc.</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Immune Response Enrichment Analysis. <bold>(A)</bold> The bubble plot shows the top five genes with the most significant differences in Monocytes between IDD and normal controls. <bold>(B)</bold> The cytokine enrichment plot displays the cytokines significantly enriched in Monocytes in IDD. <bold>(C)</bold> The radar chart illustrates the polarization states of Monocytes in IDD.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1465126-g004.tif"/>
</fig>
</sec>
<sec id="s3_4">
<label>3.4</label>
<title>Cell-cell communication analysis</title>
<p>To investigate the cellular interaction network in IDD, the R package &#x201c;Cellchat&#x201d; was performed. Compared to the control group, the number and the strength of interactions between different cell types were elevated in the IDD group (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>). Besides, we showed the relationship of the number of interactions between different cell types in the IDD and the control group. Relatively little difference was found between the groups (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5B</bold>
</xref>). Then, we focused on monocytes and found that the biggest change occurred between monocytes and macrophages. And the communication strength between the two cells decreased greatly in IDD, indicating that the interaction between macrophages and monocytes is an important factor in the occurrence of IDD (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5C</bold>
</xref>).</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Cell-cell communication analysis. <bold>(A)</bold> The bar chart illustrates the differences in the total number and strength of intercellular communication signals between the control and IDD groups, with the left panel showing communication quantity and the right panel showing communication strength. <bold>(B)</bold> The network diagram displays the interaction counts between cell types in the control and IDD groups, with lines representing interactions between cells, colored according to cell types. Thicker lines indicate more interactions between groups, with the left panel for the control group and the right panel for IDD. <bold>(C)</bold> The heatmap shows changes in the number and strength of intercellular communication signals between cell types in the control and IDD groups. Red indicates an increase or enhancement in communication quantity/strength in the IDD group, while blue indicates a decrease or reduction. The left panel represents the number of communication and the right panel represents communication strength.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1465126-g005.tif"/>
</fig>
<p>Next, we visualized the relationship between immune cells and signaling pathways in the control and IDD group in the heatmap. It demonstrated that in the control group, ANNEXIN is the most important signaling pathway, but its communication signal decreases significantly after the occurrence of IDD (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6A</bold>
</xref>). To explore the reasons for this trend, violin plots were used to show the expression of the ANNEXIN pathway between the control and IDD groups. Compared with the control group, the ligand ANXA1 showed a decreasing trend in all cell types. And monocytes, with the highest expression of receptor FPR1, may be affected (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6B</bold>
</xref>). In addition, we also observed a significant decline in the CXCL signaling pathway in monocytes after the occurrence of IDD(<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6A</bold>
</xref>). Thus, the CXCL pathway-mediated communication between monocytes and other cells was mapped. The results showed that the CXCL pathway of monocytes mainly occurred in communication with macrophages and was significantly reduced in IDD (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6C</bold>
</xref>). Therefore, the reduction of CXCL signaling in monocytes and macrophages may exacerbate the progression of IDD.</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>Changes in pathways during cellular communication <bold>(A)</bold> The heatmap displays the status of various pathways in cell communication between the control and IDD groups. The top bar chart reflects the total communication signals of all pathways within the corresponding cell types, while the right bar chart shows the total communication signals of each pathway across all cell types. The left panel represents the control group, and the right panel represents IDD. <bold>(B)</bold> The expression distribution of receptors in the ANNEXIN signaling pathway in both the control and IDD groups. <bold>(C)</bold> The network diagram illustrates interactions between the CXCL signaling pathway originating from Monocytes and other cell types.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1465126-g006.tif"/>
</fig>
</sec>
<sec id="s3_5">
<label>3.5</label>
<title>Identification of DEGs between IDD and control samples</title>
<p>2,500 DEGs were identified between IDD and control group, including 2,413 up-regulated genes and 87 down-regulated genes(<xref ref-type="fig" rid="f7">
<bold>Figures&#xa0;7A, B</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM6">
<bold>Supplementary Table&#xa0;6</bold>
</xref>). By intersecting DEGs from the conventional transcriptome with DEGs from monocytes, 80 intersecting DEGs were identified as key genes (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7C</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM7">
<bold>Supplementary Table&#xa0;7</bold>
</xref>). GO enrichment analysis indicated that these genes play significant roles in BPs, such as regulation of the viral life cycle, regulation of viral processes, and viral genome replication. Additionally, CC, like tertiary granule lumen, focal adhesion, and cell-substrate junction, were enriched, as well as MF, such as the structural constituent of the ribosome (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7D</bold>
</xref>). KEGG analysis showed they were significantly enriched in Ribosome and Coronavirus disease - COVID-19 (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7E</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM8">
<bold>Supplementary Table&#xa0;8</bold>
</xref>). This suggests that ribosomes may be indirectly involved in the regulation of degenerative inflammatory responses by supporting the protein synthesis function of monocytes. The inflammatory environment of IDD activates monocytes, which synthesize and secrete a variety of inflammatory factors and degrading enzymes with the help of ribosomes, accelerating the destruction and degeneration of the intervertebral disc. Enrichment in viral biology suggests a role for the activation of inflammatory stress pathways in viral infection-mediated monocytes in IDD progression. Certain viruses, such as herpes simplex virus, can infect disc cells, causing direct cytopathy, inflammation, or apoptosis, which can accelerate disc degeneration (<xref ref-type="bibr" rid="B39">39</xref>). Coronavirus may also have a similar effect on disc degeneration.</p>
<fig id="f7" position="float">
<label>Figure&#xa0;7</label>
<caption>
<p>Identification of DEGs related to monocytes <bold>(A)</bold> Volcano plot depicting significant DEGs between IDD and control group <bold>(B)</bold> Heatmap of the top 5 DEGs with the highest significance in up and down-regulation <bold>(C)</bold> The Venn diagram illustrates the identification of key genes involved in regulating the occurrence of IDD in monocytes. <bold>(D)</bold> GO enrichment of the intersection DEGs, displaying the top 5 most significant pathways in Biological process (BP), Cellular component (CC), and Molecular function (MF). <bold>(E)</bold> KEGG enrichment of the intersection DEGs.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1465126-g007.tif"/>
</fig>
</sec>
<sec id="s3_6">
<label>3.6</label>
<title>Screening and validation of key genes</title>
<p>A PPI network was created for the intersecting DEGs using the STRING online database. The top 100 proteins in terms of importance were screened using 10 algorithms, including Betweenness, BottleNeck, Closeness, Degree, EcCentricity, EPC, MCC, MNC, Radiality, and Stress. Six genes were identified through the intersection of these algorithms: POLR2A, RPLP0, JUN, CAT, IRF7, and RPS3 (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8A</bold>
</xref>). POLR2A, CAT, and IRF7 were included in the list of intersected DEGs, and RPLP0, JUN, and RPS3 were the genes that had a direct reciprocal relationship with the intersected DEGs. POLR2A, CAT, and IRF7 were selected as key genes for subsequent analysis. These essential genes showed up-regulation in the IDD group (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8B</bold>
</xref>). The ROC curves demonstrated POLR2A, CAT, and IRF7 all showed good efficacy for distinguishing IDD and standard samples (<xref ref-type="fig" rid="f8">
<bold>Figures&#xa0;8C&#x2013;E</bold>
</xref>). Furthermore, the expression levels of these pivotal genes were confirmed in GSE167931. IRF7 were also significantly up-regulated. The expression of CAT in the IDD group is slightly upregulated, consistent with the trend in our analysis, which also shows potential as an IDD biomarker (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8F</bold>
</xref>). IRF7 showed promising efficacy for IDD and standard samples (AUC=0.9, <xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8G</bold>
</xref>).</p>
<fig id="f8" position="float">
<label>Figure&#xa0;8</label>
<caption>
<p>Screening of key Genes. <bold>(A)</bold> Six genes were identified through a combination of 10 network topology algorithms. <bold>(B)</bold> Key genes were significantly up-regulated in the IDD group. <bold>(C)</bold> ROC curve for gene POLR2A. <bold>(D)</bold> ROC curve for gene CAT. <bold>(E)</bold> ROC curve for gene IRF7. <bold>(F)</bold> Box plot showing differential expression of key genes in the external validation cohort GSE167931. <bold>(G)</bold> ROC curve for gene IRF7 in the external validation cohort GSE167931. ***p &lt; 0.001, *p &lt; 0.05.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1465126-g008.tif"/>
</fig>
</sec>
<sec id="s3_7">
<label>3.7</label>
<title>Signaling pathways of key genes</title>
<p>GSVA showed the differences between the IDD and control groups across 50 Hallmark signaling
pathways (<xref ref-type="supplementary-material" rid="SM9">
<bold>Supplementary Table&#xa0;9</bold>
</xref>). In the IDD group, 3 pathways showed significant up-regulation and 15 pathways showed significant down-regulation (<xref ref-type="fig" rid="f9">
<bold>Figure&#xa0;9A</bold>
</xref>). IRF7 exhibits a significant negative correlation with HALLMARK_KRAS_SIGNALING_UP_PATHWAY, and down-regulation of HALLMARK_KRAS_SIGNALING_UP_PATHWAY has also been observed in IDD, suggesting that IRF7&#x2019;s promotion of IDD may be mediated by inhibition of the KRAS pathway (<xref ref-type="fig" rid="f9">
<bold>Figure&#xa0;9B</bold>
</xref>). The activation of KRAS can upregulate the expression of the anti-apoptotic protein Bcl-2, thereby inhibiting apoptosis (<xref ref-type="bibr" rid="B40">40</xref>). In IDD, KRAS may be inhibited, leading to increased apoptosis of NPCs.</p>
<fig id="f9" position="float">
<label>Figure&#xa0;9</label>
<caption>
<p>Signaling pathways associated with key genes <bold>(A)</bold> Box plot displaying differentially enriched pathways between the IDD and the control group. <bold>(B)</bold> Correlation between key genes and signaling pathways, with yellow indicating positive correlations and blue indicating negative correlations. ***p &lt; 0.001, **p &lt; 0.01, *p &lt; 0.05.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1465126-g009.tif"/>
</fig>
</sec>
<sec id="s3_8">
<label>3.8</label>
<title>Construction of key gene co-expression networks</title>
<p>To delve deeper into the function of the key genes, a co-expression network was constructed utilizing the GeneMANIA database (<xref ref-type="fig" rid="f10">
<bold>Figure&#xa0;10A</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM10">
<bold>Supplementary Table&#xa0;10</bold>
</xref>). The correlation heatmap between hub genes is shown in <xref ref-type="fig" rid="f10">
<bold>Figure&#xa0;10B</bold>
</xref>, demonstrating that most key genes were closely correlated with each other. GO and KEGG enrichment analysis found that it is related to lipid metabolism and peroxide pathways. This suggests that three hub genes and closely interacting genes may be involved in IDD progression by mediating these processes (<xref ref-type="fig" rid="f10">
<bold>Figures&#xa0;10C, D</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM11">
<bold>Supplementary Table&#xa0;11</bold>
</xref>). Specifically, lipid metabolism disorders can lead to abnormal deposition of lipids in the intervertebral discs, triggering an inflammatory response (<xref ref-type="bibr" rid="B41">41</xref>). Lipid peroxidation accelerates disc cell damage and matrix degradation by increasing oxidative stress and promoting an inflammatory response (<xref ref-type="bibr" rid="B42">42</xref>). These processes interact with each other to form a vicious circle that ultimately leads to the progression of disc degeneration.</p>
<fig id="f10" position="float">
<label>Figure&#xa0;10</label>
<caption>
<p>Co-expressed Gene Analysis. <bold>(A)</bold> Gene co-expression network plot, the size of the circles represents the overall interaction strength of the corresponding proteins within the network, while the thickness of the lines indicates the strength of interactions between pairs of proteins. <bold>(B)</bold> Heatmap of correlations between key genes. <bold>(C)</bold> GO enrichment lollipop plot of co-expressed genes. <bold>(D)</bold> KEGG enrichment lollipop plot of co-expressed genes. ***p &lt; 0.001, ****p &lt; 0.0001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1465126-g010.tif"/>
</fig>
</sec>
<sec id="s3_9">
<label>3.9</label>
<title>Correlation network construction of key genes</title>
<p>In order to further study the way of hub gene regulation, we constructed mRNA, TF, and ceRNA regulatory networks. An mRNA-miRNA-lncRNA interaction network was constructed using the key genes. Two miRNAs (miR-30a-5p and miR-30b-5p) were found to bind to CAT. A total of 23 lncRNAs were identified as target lncRNAs. The ceRNA network is shown in <xref ref-type="fig" rid="f11">
<bold>Figure&#xa0;11A</bold>
</xref> (<xref ref-type="supplementary-material" rid="SM12">
<bold>Supplementary Table&#xa0;12</bold>
</xref>). The corresponding mRNA/RBP pairs of hub mRNAs with pairwise information were searched and downloaded using the StarBase online database. Based on the relationships identified among the target genes from the online dataset, we constructed an intricate RBP-mRNA network (<xref ref-type="fig" rid="f11">
<bold>Figure&#xa0;11B</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM13">
<bold>Supplementary Table&#xa0;13</bold>
</xref>). Transcription factors (TFs) that bind to co-expressed genes were searched using the TRRUST database, identifying interaction relationship data for 2 target genes and 17 TFs (<xref ref-type="fig" rid="f11">
<bold>Figure&#xa0;11C</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM14">
<bold>Supplementary Table&#xa0;14</bold>
</xref>).</p>
<fig id="f11" position="float">
<label>Figure&#xa0;11</label>
<caption>
<p>Construction of Key Gene-Related Networks. <bold>(A)</bold> lncRNA&#x2013;miRNA&#x2013;mRNA network of key genes. Blue represents lncRNA, yellow represents miRNA, and pink represents mRNA. <bold>(B)</bold> RBP-mRNA regulatory network of key genes. Yellow represents RBP, and pink represents mRNA. <bold>(C)</bold> mRNA-TF interaction network of key genes. Pink represents target genes; blue represents transcription factors (TF).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1465126-g011.tif"/>
</fig>
</sec>
<sec id="s3_10">
<label>3.10</label>
<title>Differential expression of IRF7 was the most significant, and knockdown of IRF7 alleviated IDD in NPCs</title>
<p>Using RT-qPCR analysis, it was noted that IRF7, POLR2A, and CAT exhibited significant upregulation in the TBHP-induced degeneration group, with IRF7 showing the most significant increase in expression (<xref ref-type="supplementary-material" rid="SF1">
<bold>Supplementary Figure&#xa0;1</bold>
</xref>). IDD can cause an imbalance between catabolism and anabolism in the ECM, leading to structural changes in the intervertebral disk (<xref ref-type="bibr" rid="B43">43</xref>). To investigate the potential of knocking down IRF7 to reverse IDD <italic>in vitro</italic>, we set up four groups of experiments: standard group, IDD group (TBHP), Si-NC group (TBHP + Si-NC), and Si-IRF7 group (TBHP + Si-IRF7). The efficiency of the IRF7 knockdown in NPCs was verified by RT-qPCR (<xref ref-type="supplementary-material" rid="SF1">
<bold>Supplementary Figure&#xa0;1</bold>
</xref>). It was found that knocking down IRF7 increased the expression of COL2A1 in the Si-IRF7 group while decreasing the expression of MMP13 compared to the Si-NC group (<xref ref-type="fig" rid="f12">
<bold>Figures&#xa0;12A, B, E</bold>
</xref>). It indicates that the knockdown of IRF7 can reverse the metabolic imbalance of the extracellular matrix (ECM). Besides,the knockdown of IRF7 decreased the expression of NLRP3 and IL-1&#x3b2; compared to the Si-NC group (<xref ref-type="fig" rid="f12">
<bold>Figures&#xa0;12C&#x2013;E</bold>
</xref>). This indicates that knocking down IRF7 can alleviate the inflammation of IDD. In conclusion, these findings demonstrate that the knockdown of IRF7 can slow the progression of NPC degeneration.</p>
<fig id="f12" position="float">
<label>Figure&#xa0;12</label>
<caption>
<p>Knockdown of the IRF7 gene can alleviate the degeneration of NPCs. <bold>(A&#x2013;D)</bold> RT-qPCR shows changes in COL2A1, MMP13, NLRP3 and IL-1&#x3b2; expression levels. <bold>(E)</bold> Immunofluorescence shows changes in COL2A1, MMP13, NLRP3 and IL-1&#x3b2; expression levels.(scale bar: 20&#x3bc;m) The data were presented as the mean&#x2009;&#xb1;&#x2009;SD. ***p &lt; 0.001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1465126-g012.tif"/>
</fig>
</sec>
<sec id="s3_11">
<label>3.11</label>
<title>
<italic>In vivo</italic> therapeutic effects of knocking down IRF7 in a rat model of IDD</title>
<p>Finally, we investigated the potential of knocking down IRF7 to reverse IDD <italic>in vivo</italic>. The flowchart of the animal experiment is shown in <xref ref-type="fig" rid="f13">
<bold>Figure&#xa0;13A</bold>
</xref>. Immunohistochemistry showed higher IRF7 expression in the Si-NC group than in the control
group, and IRF7 was successfully knocked down <italic>in vivo</italic> (<xref ref-type="supplementary-material" rid="SF2">
<bold>Supplementary Figure&#xa0;2</bold>
</xref>). 4 weeks after the knockdown of IRF7, X-ray analysis showed an increased intervertebral space height in the Si-IRF7 group compared to the Si-NC group, with corresponding increases in DHI scores (<xref ref-type="fig" rid="f13">
<bold>Figures&#xa0;13B, C</bold>
</xref>). MRI results indicated significantly higher signal intensity in the Si-IRF7 group than in the Si-NC group, consistent with the grading results (<xref ref-type="fig" rid="f13">
<bold>Figures&#xa0;13D, E</bold>
</xref>). Both X-ray and MRI analyses confirmed that the knockdown of IRF7 alleviated IDD. Histological analysis further validated the therapeutic effects of IRF7 knockdown. It was found that NPs in the Si-NC group gradually shrank with blurred borders and were replaced by AF contents. In contrast, the NPs in the Si-IRF7 group showed significantly restored morphology (<xref ref-type="fig" rid="f13">
<bold>Figure&#xa0;13F</bold>
</xref>). The expression of COL2A1, MMP13, NLRP3 and IL-1&#x3b2; in NP tissues was accessed with immunohistochemical staining. The knockdown of IRF7 significantly restored the expression of COL2A1, while the expression of MMP13, NLRP3 and IL-1&#x3b2; was significantly reduced (<xref ref-type="fig" rid="f14">
<bold>Figure&#xa0;14</bold>
</xref>). These findings collectively demonstrate that the knockdown of IRF7 can inhibit inflammation and reverse the metabolic imbalance of the ECM, thereby alleviating the progression of IDD.</p>
<fig id="f13" position="float">
<label>Figure&#xa0;13</label>
<caption>
<p>Therapeutic effects of IRF7 knockdown in rats. <bold>(A)</bold> Flowchart of the animal experiment <bold>(B, C)</bold>. X-ray images and DHI scores 4 weeks after surgery <bold>(D, E)</bold>. T2-weighted MRI images and Pfirrmann grading scores 4 weeks after surgery; <bold>(F)</bold>. Representative images of HE and SO&amp;FG staining at 4 weeks after surgery. (original images, scale bar: 500&#x2009;&#x3bc;m; enlarged images, scale bar: 100&#x3bc;m) The data were presented as the mean&#x2009;&#xb1;&#x2009;SD. ***p &lt; 0.001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1465126-g013.tif"/>
</fig>
<fig id="f14" position="float">
<label>Figure&#xa0;14</label>
<caption>
<p>Representative images of immunohistochemistry at 4 weeks after surgery (scale bar: 20&#x3bc;m).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1465126-g014.tif"/>
</fig>
</sec>
<sec id="s3_12">
<label>3.12</label>
<title>Forecast of potential therapeutic drugs for IDD</title>
<p>To identify potential therapeutic drugs for IDD, 10 small molecule compounds most likely to serve
as potential drugs were predicted based on the CMAP database (<xref ref-type="supplementary-material" rid="SM15">
<bold>Supplementary Table&#xa0;15</bold>
</xref>). Homoharringtonine, which exhibits intense toxicity, was excluded from the analysis as a potential drug. Additionally, the structure of QW-BI-011 could not be found. Therefore, eight small-molecule compounds were identified as potential drugs: Tyrphostin-AG-835, Periplocymarin, Mirin, MLN-4924, AZ-10417808, Kinetin-riboside, Securinine, and Quinoclamine. Subsequently, molecular docking analysis of potential small-molecule drugs with IRF7 was performed. The molecular docking demonstrated that the binding energies of IRF7 with these potential small molecule drugs were less than -3 kcal/mol, indicating strong binding affinity. This suggests that these small-molecule drugs may exert therapeutic effects by binding to IRF7 for IDD treatment (<xref ref-type="fig" rid="f15">
<bold>Figure&#xa0;15</bold>
</xref>).</p>
<fig id="f15" position="float">
<label>Figure&#xa0;15</label>
<caption>
<p>Molecular docking of potential drug molecules with their corresponding target proteins. <bold>(A)</bold> Tyrphostin AG 835 <bold>(B)</bold> Periplocymarin <bold>(C)</bold> Mirin <bold>(D)</bold> MLN-4924 <bold>(E)</bold> AZ-10417808 <bold>(F)</bold> Kinetin riboside <bold>(G)</bold> Securinine <bold>(H)</bold> Quinoclamine.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1465126-g015.tif"/>
</fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p>LBP is a severe medical and social problem worldwide. It is also a cause of total disability in middle-aged and older adults and the most common reason for activity limitation in patients under 45 years of age (<xref ref-type="bibr" rid="B44">44</xref>&#x2013;<xref ref-type="bibr" rid="B46">46</xref>). IDD is the leading cause of LBP. A growing body of research suggests that in addition to biomechanical factors, the autoimmune system plays an essential role in the degenerative process of this disease, including immune cells and cytokines (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B47">47</xref>). When the AF or CEP suffers damage or degeneration, it can lead to the infiltration of immune cells into the intervertebral disc. This migration leads to inflammation within the disc, resulting in increased cytokine and chemokine levels. This vicious cycle of inflammation-driven catabolism accelerates ECM breakdown (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B43">43</xref>). Therefore, the treatment strategy for IDD should no longer be limited to traditional physical therapy, surgical intervention, and pharmacological analgesia but gradually shift to modulating the immune response, suppressing the inflammatory response, and promoting intervertebral disc repair. These emerging therapies are expected to provide patients with IDD with more effective and lasting solutions to reduce LBP symptoms and improve quality of life.</p>
<p>Monocytes are a type of blood cell originating from bone marrow precursors and associated with the mononuclear phagocytic cell system (<xref ref-type="bibr" rid="B48">48</xref>). Monocytes are the second-line defense cells of the innate immune system after neutrophils and can engulf foreign particles. They can differentiate into their subpopulations and macrophages depending on the necessities of the microenvironment. In addition, monocytes produce cytokines and act as antigen-presenting cells (APCs) (<xref ref-type="bibr" rid="B49">49</xref>). In this study, machine-learning techniques were used to screen for immune cells, identifying monocytes as key players in the development and progression of IDD. Consistent with our findings, Guo et&#xa0;al. found through bioinformatics analysis that monocytes infiltration was more frequent in the IDD group compared to the healthy group (<xref ref-type="bibr" rid="B50">50</xref>). Inflammation is a crucial factor in IDD progression, and IL-17 has been shown to recruit monocytes and neutrophils to sites of inflammation by increasing chemokine production (<xref ref-type="bibr" rid="B43">43</xref>). It can further amplify the inflammatory cascade, promote the degradation of the ECM, and accelerate the progression of IDD. As immune cells, monocytes initiate the defense against inflammation upon recruitment to inflammation sites under the chemotaxis of cytokines (<xref ref-type="bibr" rid="B51">51</xref>). A recent study also found that monocytes are abnormally activated in the late stages of IDD (<xref ref-type="bibr" rid="B52">52</xref>). Therefore, monocytes may play a pivotal role in the progression of IDD, leading to increased inflammation within the intervertebral disc.</p>
<p>The interaction of cytokines with intervertebral disc cells is one of the crucial mechanisms of IDD. NPCs undergo a series of biological responses stimulated by cytokines, including apoptosis, proliferation, and matrix degradation (<xref ref-type="bibr" rid="B53">53</xref>). For example, IL-1&#x3b2; and TNF-&#x3b1; can promote the secretion of more inflammatory factors and matrix-degrading enzymes from NP and AF cells by activating the NF-&#x3ba;B and MAPK signaling pathways, thus forming a vicious circle and accelerating IDD (<xref ref-type="bibr" rid="B54">54</xref>). These cytokines promote the inflammatory response and lead to the degradation of the ECM by regulating the expression of enzymes such as matrix metalloproteinases (MMPs) and ADAMTS, thus accelerating IDD (<xref ref-type="bibr" rid="B55">55</xref>). In addition, it has been found that specific anti-inflammatory cytokines, such as IL-10, are expressed at low levels in intervertebral disc tissues, which may contribute to uncontrolled inflammation and increased degeneration (<xref ref-type="bibr" rid="B56">56</xref>). To systematically elucidate the effects of cytokines on monocytes in IDD, the present study identified an important role of type I interferon(IFN-a1, IFN-b) in the monocytes by IREA analysis. Type I interferons play a crucial role in antiviral immunity and influence inflammatory response and tissue repair by modulating the function of multiple immune cells. They regulate the innate immune response by promoting antigen presentation and natural killer cell function (<xref ref-type="bibr" rid="B57">57</xref>). Besides, they can modulate inflammation by affecting key factors in various signaling pathways such as the JAK/STAT pathway, TLRs pathway, NF-&#x3ba;B pathway, PI3K/AKT pathway, and MAPK pathway (<xref ref-type="bibr" rid="B58">58</xref>). Secondly, IFN-Is can trigger the adaptive immune system and promote the development of high-affinity antigenic immune cell responses and immune memory (<xref ref-type="bibr" rid="B59">59</xref>, <xref ref-type="bibr" rid="B60">60</xref>). During disc degeneration, monocytes may increase type I interferons, causing monocytes mono-a polarization, increasing oxidative stress and promoting inflammatory responses to accelerate disc cell damage and matrix degradation.</p>
<p>Cell-cell communication analysis in IDD revealed that the ANNEXIN pathway was inhibited in the IDD group. Annexins were described as Ca<sup>2+</sup>-regulated membrane-binding modules that respond to cellular stress and control mammal inflammatory responses (<xref ref-type="bibr" rid="B61">61</xref>). Annexins have been proven to play an anti-inflammatory role in various diseases. Jia et&#xa0;al. found that Annexin A5 inhibited the release of pro-inflammatory mediators <italic>in vitro</italic> and reduced the production of reactive oxygen species in osteoarthritis, which protected chondrocyte necrosis and apoptosis (<xref ref-type="bibr" rid="B62">62</xref>). Similarly, You et&#xa0;al. found that Annexin A5 depletion exacerbates vascular remodelling and dysfunction while upregulating the expression of age- and inflammation-related proteins (<xref ref-type="bibr" rid="B63">63</xref>). Thus, the inhibition of the ANNEXIN pathway in IDD may prevent it from responding adequately to inflammatory stimuli in the intervertebral disc, contributing to the progression of IDD. As a member of the Annexin family, Annexin A1 exerts anti-inflammatory and pro-catabolic effects in various ways (<xref ref-type="bibr" rid="B64">64</xref>). In our study, we also found that the ligand ANXA1 showed a downward trend in all cell types in IDD, which may lead to a decrease in the anti-inflammatory effect of the IDD group. Michael Scannell found that AnxA1 can induce monocytes recruitment and enhance phagocytosis, confirming our conjecture (<xref ref-type="bibr" rid="B65">65</xref>). Additionally, Shao et&#xa0;al. found that NPCs can seek the help of neutrophils through the ANXA1-FPR1 pathway to alleviate intervertebral disc inflammation (<xref ref-type="bibr" rid="B66">66</xref>). Our study found that the receptor FPR1 expression was highest among monocytes. Therefore, the ANXA1-FRP1 pathway may alleviate inflammation in the intervertebral disc by recruiting monocytes.</p>
<p>Subsequently, we intersected the genes specifically expressed in monocytes from the single-cell data with the DEGs between IDD and healthy controls from the transcriptome. The core genes POLR2A, CAT, and IRF7 were identified using ten algorithms. The differential expression of CAT and IRF7 was validated in an external dataset, GSE167931, further confirming their central roles in IDD development. Similar results were obtained from <italic>in vitro</italic> experiments, where significantly higher expression of POLR2A, CAT, and IRF7 was observed in TBHP-induced IDD samples, verifying the reliability of our analysis.</p>
<p>RNA polymerase II subunit A (POLR2A) is the largest subunit encoding RNA polymerase II, which plays a crucial role in transcription. Although no literature directly supports its relationship with IDD, external validation has demonstrated high expression of POLR2A in the IDD group. GSVA supported the significant correlation between POLR2A and numerous Hallmark pathways enriched in the IDD group, indicating that abnormalities in POLR2A can lead to changes in multiple pathways, such as HALLMARK_MITOTIC_SPINDLE and HALLMARK_KARS_SIGNALING_UP, thereby affecting IDD progression. CAT encodes catalase, a critical antioxidant enzyme that protects cells from oxidative damage. Xiang et&#xa0;al. found that Nrf2 signaling promotes the transcription of downstream antioxidant genes, including CAT, which in turn come to protect against oxidative stress in intervertebral disc cells (<xref ref-type="bibr" rid="B67">67</xref>). Xiao et&#xa0;al. found that CAT could significantly reduce oxidative stress in intervertebral disc cells, thereby reducing apoptosis and inflammation and slowing down disc degeneration (<xref ref-type="bibr" rid="B68">68</xref>). GSVA analysis also showed that CAT was associated with HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY, further supporting its protective role in oxidative stress regulation. Thus, CAT may slow the progression of IDD by acting on the process of oxidative stress.</p>
<p>Interferon regulatory factor 7 (IRF7), a member of the IRF family, is a crucial regulator of type I interferon production (<xref ref-type="bibr" rid="B69">69</xref>). IRF7 can form a positive feedback loop with IFN-Is, significantly enhancing their expression and maintaining high levels of IFN-Is, thus actively regulating IFN-I production (<xref ref-type="bibr" rid="B70">70</xref>, <xref ref-type="bibr" rid="B71">71</xref>). Koroth et&#xa0;al. found that interferons can play a crucial role in disc degeneration by modulating macrophage polarisation and influencing the inflammatory response of disc cells (<xref ref-type="bibr" rid="B72">72</xref>). Several studies have shown that IRF7 regulates inflammation in various diseases, however, its role in IDD remains unelucidated. Chen et&#xa0;al. demonstrated that IRF7 can promote apoptosis of intestinal epithelial cells and the release of pro-inflammatory proteins by activating the Nod-like receptor (NLR) pathway, thereby exacerbating intestinal inflammation (<xref ref-type="bibr" rid="B73">73</xref>). He et&#xa0;al. found that ILC2 from asthmatics exhibited much higher levels of IRF7 than healthy donors upon stimulation with papain or IL-33, suggesting that IRF7 may promote the development of asthma (<xref ref-type="bibr" rid="B74">74</xref>). Moreover, Aryl Hydrocarbon Receptor Interacting Protein (AIP) can inhibit IRF7 by antagonizing its nuclear localization, hindering IRF7-induced IFN-I production, reducing immune responses, and promoting aberrant inflammation (<xref ref-type="bibr" rid="B75">75</xref>).In this study, IRF7 was identified as a critical gene for IDD through PPI network analysis and was significantly up-regulated in IDD samples. <italic>In vitro</italic>, it was found that knocking down IRF7 can slow the progression of IDD. Compared with the Si-NC group, the expression levels of COL2A1 increased, while the expression level of MMP13, NLRP3 and IL-1&#x3b2; decreased after IRF7 knockdown. Subsequently, an IDD model in rats was constructed to verify the function of IRF7 further. X-ray showed that the intervertebral disc height in the Si-IRF7 group was higher than in the Si-NC group. MRI revealed that the water content of the intervertebral disc in the Si-IRF7 group was also higher than in the Si-NC group. HE and SF staining demonstrated that the morphology of the NP in the Si-IRF7 group was better restored than in the Si-NC group. Finally, immunohistochemistry confirmed that knocking down IRF7 can delay the progression of IDD by regulating inflammation and the metabolism of the extracellular matrix. Therefore, this study demonstrates through <italic>in vivo</italic> and <italic>in vitro</italic> experiments that IRF7 is an essential therapeutic target for IDD, and knocking down IRF7 can significantly alleviate IDD.</p>
<p>Eight small-molecule drugs were then screened that may alleviate IDD: Tyrphostin-AG-835, Periplocymarin, Mirin, MLN-4924, AZ-10417808, Kinetin-riboside, Securinine, and Quinoclamine. Molecular docking showed that IRF7 tightly binds to these potential small-molecule drugs, suggesting they may exert therapeutic effects by binding to IRF7 in IDD.</p>
<p>However, this study is subject to certain constraints. Firstly, the crucial role of monocytes and IRF7 in IDD has been demonstrated, but the specific mechanisms of action remain to be further investigated. Additionally, conducting <italic>in vitro</italic> drug tests and clinical trials is crucial to confirm the therapeutic effect of these small-molecule drugs on the progression of IDD.</p>
</sec>
<sec id="s5" sec-type="conclusions">
<label>5</label>
<title>Conclusion</title>
<p>Monocytes are essential in the progression of IDD, with the polarisation state of monocytes mediated by type I interferon potentially exacerbating the inflammatory response in the intervertebral disc. IRF7 has been identified as a key target for IDD, and its role in causing IDD has been confirmed through both <italic>in vitro</italic> and <italic>in vivo</italic> studies. These studies provide novel insights into potential therapeutic targets for IDD. Future research should encompass more extensive clinical sample analyses to confirm these discoveries and facilitate their translation into clinical applications.</p>
</sec>
</body>
<back>
<sec id="s6" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Material</bold>
</xref>. Further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s7" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The animal study was approved by the Animal Ethics Committee of Nanchang University. The study was conducted in accordance with the local legislation and institutional requirements.</p>
</sec>
<sec id="s8" sec-type="author-contributions">
<title>Author contributions</title>
<p>PX: Writing &#x2013; review &amp; editing, Writing &#x2013; original draft, Supervision, Software, Conceptualization. KL: Writing &#x2013; review &amp; editing, Investigation, Writing &#x2013; original draft, Validation. JY: Writing &#x2013; review &amp; editing, Software, Methodology, Formal analysis. JZ: Writing &#x2013; review &amp; editing, Validation, Methodology, Writing &#x2013; original draft. HP: Writing &#x2013; original draft, Validation. CP: Validation, Writing &#x2013; original draft, Methodology. WX: Supervision, Writing &#x2013; review &amp; editing. JT: Writing &#x2013; review &amp; editing, Investigation. TL: Writing &#x2013; review &amp; editing, Methodology. GH: Software, Formal analysis, Writing &#x2013; original draft. XLC: Software, Formal analysis, Writing &#x2013; original draft. XM: Writing &#x2013; review &amp; editing, Methodology. DH: Writing &#x2013; review &amp; editing, Supervision. XGC: Writing &#x2013; review &amp; editing, Supervision, Project administration, Funding acquisition, Conceptualization.</p>
</sec>
<sec id="s9" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This research was funded by the National Natural Science Foundation of China (Grant Number:82060403) and International Scientific and Technological Cooperation Project (Grant Number:20232BBH80001).</p>
</sec>
<sec id="s10" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s11" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s12" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fimmu.2024.1465126/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fimmu.2024.1465126/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Table1.xls" id="SM1" mimetype="application/vnd.ms-excel">
<label>Supplementary Table&#xa0;1</label>
<caption>
<p>Primers used in this study.</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Table1.xls" id="SM2" mimetype="application/vnd.ms-excel">
<label>Supplementary Table&#xa0;2</label>
<caption>
<p>The result of ssGSEA.</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Table1.xls" id="SM3" mimetype="application/vnd.ms-excel">
<label>Supplementary Table&#xa0;3</label>
<caption>
<p>DEGs in monocytes of IDD and Control groups.</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Table1.xls" id="SM4" mimetype="application/vnd.ms-excel">
<label>Supplementary Table&#xa0;4</label>
<caption>
<p>The result of IREA(cytokines).</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Table1.xls" id="SM5" mimetype="application/vnd.ms-excel">
<label>Supplementary Table&#xa0;5</label>
<caption>
<p>The result of IREA(cell polarisation).</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Table1.xls" id="SM6" mimetype="application/vnd.ms-excel">
<label>Supplementary Table&#xa0;6</label>
<caption>
<p>2500 DEGs between IDD and control groups.</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Table1.xls" id="SM7" mimetype="application/vnd.ms-excel">
<label>Supplementary Table&#xa0;7</label>
<caption>
<p>Intersecting 80 DEGs.</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Table1.xls" id="SM8" mimetype="application/vnd.ms-excel">
<label>Supplementary Table&#xa0;8</label>
<caption>
<p>The results of the GO and KEGG enrichment analysis.</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Table1.xls" id="SM9" mimetype="application/vnd.ms-excel">
<label>Supplementary Table&#xa0;9</label>
<caption>
<p>The results of GSVA.</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Table1.xls" id="SM10" mimetype="application/vnd.ms-excel">
<label>Supplementary Table&#xa0;10</label>
<caption>
<p>The co-expression network of key genes.</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Table1.xls" id="SM11" mimetype="application/vnd.ms-excel">
<label>Supplementary Table&#xa0;11</label>
<caption>
<p>GO and KEGG enrichment of 23 genes.</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Table1.xls" id="SM12" mimetype="application/vnd.ms-excel">
<label>Supplementary Table&#xa0;12</label>
<caption>
<p>The results of the ceRNA network.</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Table1.xls" id="SM13" mimetype="application/vnd.ms-excel">
<label>Supplementary Table&#xa0;13</label>
<caption>
<p>The results of the RBP network.</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Table1.xls" id="SM14" mimetype="application/vnd.ms-excel">
<label>Supplementary Table&#xa0;14</label>
<caption>
<p>The results of the TF network.</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Table1.xls" id="SM15" mimetype="application/vnd.ms-excel">
<label>Supplementary Table&#xa0;15</label>
<caption>
<p>The results of small-molecule drug prediction..</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Image1.jpeg" id="SF1" mimetype="image/jpeg">
<label>Supplementary Figure&#xa0;1</label>
<caption>
<p>Differential expression of three hub genes and IRF7 was knocked down <italic>in vitro</italic>.</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Image2.jpeg" id="SF2" mimetype="image/jpeg">
<label>Supplementary Figure&#xa0;2</label>
<caption>
<p>IRF7 was successfully knocked down <italic>in vivo</italic>.</p>
</caption>
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wei</surname> <given-names>B</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Li</surname> <given-names>W</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Yan</surname> <given-names>M</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>Z</given-names>
</name>
<etal/>
</person-group>. <article-title>Innovative immune mechanisms and antioxidative therapies of intervertebral disc degeneration</article-title>. <source>Front Bioengineering Biotechnol</source>. (<year>2022</year>) <volume>10</volume>:<elocation-id>1023877</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fbioe.2022.1023877</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname> <given-names>D</given-names>
</name>
<name>
<surname>Mei</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Song</surname> <given-names>C</given-names>
</name>
<name>
<surname>Cheng</surname> <given-names>K</given-names>
</name>
<name>
<surname>Cai</surname> <given-names>W</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Exploration of the mode of death and potential death mechanisms of nucleus pulposus cells</article-title>. <source>Eur J Clin Invest</source>. (<year>2024</year>) <volume>54</volume>:<elocation-id>e14226</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/eci.14226</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>S</given-names>
</name>
<name>
<surname>Du</surname> <given-names>J</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Chang</surname> <given-names>Z</given-names>
</name>
<etal/>
</person-group>. <article-title>From hyperglycemia to intervertebral disc damage: exploring diabetic-induced disc degeneration</article-title>. <source>Front Immunol</source>. (<year>2024</year>) <volume>15</volume>:<elocation-id>1355503</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2024.1355503</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Swahn</surname> <given-names>H</given-names>
</name>
<name>
<surname>Mertens</surname> <given-names>J</given-names>
</name>
<name>
<surname>Olmer</surname> <given-names>M</given-names>
</name>
<name>
<surname>Myers</surname> <given-names>K</given-names>
</name>
<name>
<surname>Mondala</surname> <given-names>TS</given-names>
</name>
<name>
<surname>Natarajan</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>Shared and compartment-specific processes in nucleus pulposus and annulus fibrosus during intervertebral disc degeneration</article-title>. <source>Advanced Sci (Weinheim Baden-Wurttemberg Germany)</source>. (<year>2024</year>) <volume>11</volume>:<elocation-id>e2309032</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/advs.202309032</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Minamisawa</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Shirogane</surname> <given-names>T</given-names>
</name>
<name>
<surname>Watanabe</surname> <given-names>I</given-names>
</name>
<name>
<surname>Dezawa</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Histological analysis of nucleus pulposus tissue from patients with lumbar disc herniation after condoliase administration</article-title>. <source>JOR Spine</source>. (<year>2024</year>) <volume>7</volume>:<elocation-id>e1328</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/jsp2.1328</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Tian</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Shofer</surname> <given-names>FS</given-names>
</name>
<name>
<surname>Qin</surname> <given-names>L</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>H</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Tnfaip8 and tipe2 gene deletion ameliorates immediate proteoglycan loss and inflammatory responses in the injured mouse intervertebral disc</article-title>. <source>Am J Phys Med Rehabil</source>. (<year>2024</year>) <volume>103</volume>:<page-range>918&#x2013;24</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/PHM.0000000000002488</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname> <given-names>C</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>P</given-names>
</name>
<name>
<surname>Peng</surname> <given-names>R</given-names>
</name>
<name>
<surname>Li</surname> <given-names>F</given-names>
</name>
<name>
<surname>Fang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Bioenergetic dysfunction in the pathogenesis of intervertebral disc degeneration</article-title>. <source>Pharmacol Res</source>. (<year>2024</year>) <volume>202</volume>:<fpage>107119</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.phrs.2024.107119</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Pan</surname> <given-names>D</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>B</given-names>
</name>
<name>
<surname>Xing</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>The potential role and trend of HIF&#x2212;1&#x3b1; in intervertebral disc degeneration: Friend or foe? (Review)</article-title>. <source>Mol Med Rep</source>. (<year>2021</year>) <volume>23</volume>:<fpage>239</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3892/mmr.2021.11878</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>B</given-names>
</name>
<name>
<surname>Luo</surname> <given-names>ZJ</given-names>
</name>
</person-group>. <article-title>The immune privilege of the intervertebral disc: implications for intervertebral disc degeneration treatment</article-title>. <source>Int J Med Sci</source>. (<year>2020</year>) <volume>17</volume>:<page-range>685&#x2013;92</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.7150/ijms.42238</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Capossela</surname> <given-names>S</given-names>
</name>
<name>
<surname>Schl&#xe4;fli</surname> <given-names>P</given-names>
</name>
<name>
<surname>Bertolo</surname> <given-names>A</given-names>
</name>
<name>
<surname>Janner</surname> <given-names>T</given-names>
</name>
<name>
<surname>Stadler</surname> <given-names>BM</given-names>
</name>
<name>
<surname>P&#xf6;tzel</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Degenerated human intervertebral discs contain autoantibodies against extracellular matrix proteins</article-title>. <source>Eur Cells Materials</source>. (<year>2014</year>) <volume>27</volume>:<page-range>251&#x2013;63</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.22203/eCM.v027a18</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vergroesen</surname> <given-names>PP</given-names>
</name>
<name>
<surname>Kingma</surname> <given-names>I</given-names>
</name>
<name>
<surname>Emanuel</surname> <given-names>KS</given-names>
</name>
<name>
<surname>Hoogendoorn</surname> <given-names>RJ</given-names>
</name>
<name>
<surname>Welting</surname> <given-names>TJ</given-names>
</name>
<name>
<surname>van Royen</surname> <given-names>BJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Mechanics and biology in intervertebral disc degeneration: a vicious circle</article-title>. <source>Osteoarthritis Cartilage</source>. (<year>2015</year>) <volume>23</volume>:<page-range>1057&#x2013;70</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.joca.2015.03.028</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arai</surname> <given-names>KI</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>F</given-names>
</name>
<name>
<surname>Miyajima</surname> <given-names>A</given-names>
</name>
<name>
<surname>Miyatake</surname> <given-names>S</given-names>
</name>
<name>
<surname>Arai</surname> <given-names>N</given-names>
</name>
<name>
<surname>Yokota</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Cytokines: coordinators of immune and inflammatory responses</article-title>. <source>Annu Rev Biochem</source>. (<year>1990</year>) <volume>59</volume>:<fpage>783</fpage>&#x2013;<lpage>836</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev.bi.59.070190.004031</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Briukhovetska</surname> <given-names>D</given-names>
</name>
<name>
<surname>D&#xf6;rr</surname> <given-names>J</given-names>
</name>
<name>
<surname>Endres</surname> <given-names>S</given-names>
</name>
<name>
<surname>Libby</surname> <given-names>P</given-names>
</name>
<name>
<surname>Dinarello</surname> <given-names>CA</given-names>
</name>
<name>
<surname>Kobold</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Interleukins in cancer: from biology to therapy</article-title>. <source>Nat Rev Cancer</source>. (<year>2021</year>) <volume>21</volume>:<page-range>481&#x2013;99</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41568-021-00363-z</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Le Maitre</surname> <given-names>CL</given-names>
</name>
<name>
<surname>Freemont</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Hoyland</surname> <given-names>JA</given-names>
</name>
</person-group>. <article-title>The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration</article-title>. <source>Arthritis Res Ther</source>. (<year>2005</year>) <volume>7</volume>:<page-range>R732&#x2013;45</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/ar1732</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoyland</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Le Maitre</surname> <given-names>C</given-names>
</name>
<name>
<surname>Freemont</surname> <given-names>AJ</given-names>
</name>
</person-group>. <article-title>Investigation of the role of IL-1 and TNF in matrix degradation in the intervertebral disc</article-title>. <source>Rheumatol (Oxford England)</source>. (<year>2008</year>) <volume>47</volume>:<page-range>809&#x2013;14</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/rheumatology/ken056</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Phillips</surname> <given-names>KL</given-names>
</name>
<name>
<surname>Chiverton</surname> <given-names>N</given-names>
</name>
<name>
<surname>Michael</surname> <given-names>AL</given-names>
</name>
<name>
<surname>Cole</surname> <given-names>AA</given-names>
</name>
<name>
<surname>Breakwell</surname> <given-names>LM</given-names>
</name>
<name>
<surname>Haddock</surname> <given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>The cytokine and chemokine expression profile of nucleus pulposus cells: implications for degeneration and regeneration of the intervertebral disc</article-title>. <source>Arthritis Res Ther</source>. (<year>2013</year>) <volume>15</volume>:<fpage>R213</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/ar4408</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Phillips</surname> <given-names>KL</given-names>
</name>
<name>
<surname>Cullen</surname> <given-names>K</given-names>
</name>
<name>
<surname>Chiverton</surname> <given-names>N</given-names>
</name>
<name>
<surname>Michael</surname> <given-names>AL</given-names>
</name>
<name>
<surname>Cole</surname> <given-names>AA</given-names>
</name>
<name>
<surname>Breakwell</surname> <given-names>LM</given-names>
</name>
<etal/>
</person-group>. <article-title>Potential roles of cytokines and chemokines in human intervertebral disc degeneration: interleukin-1 is a master regulator of catabolic processes</article-title>. <source>Osteoarthritis Cartilage</source>. (<year>2015</year>) <volume>23</volume>:<page-range>1165&#x2013;77</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.joca.2015.02.017</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>S</given-names>
</name>
<name>
<surname>Pan</surname> <given-names>X</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Tu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Hong</surname> <given-names>W</given-names>
</name>
<name>
<surname>Ren</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>IL-37 alleviates intervertebral disc degeneration via the IL-1R8/NF-&#x3ba;B pathway</article-title>. <source>Osteoarthritis Cartilage</source>. (<year>2023</year>) <volume>31</volume>:<page-range>588&#x2013;99</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.joca.2023.01.006</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tian</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Chu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>X</given-names>
</name>
<name>
<surname>Xue</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Deng</surname> <given-names>W</given-names>
</name>
</person-group>. <article-title>Astragaloside IV attenuates IL-1&#x3b2;-induced intervertebral disc degeneration through inhibition of the NF-&#x3ba;B pathway</article-title>. <source>J Orthopaedic Surg Res</source>. (<year>2022</year>) <volume>17</volume>:<fpage>545</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13018-022-03438-1</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Purmessur</surname> <given-names>D</given-names>
</name>
<name>
<surname>Freemont</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Hoyland</surname> <given-names>JA</given-names>
</name>
</person-group>. <article-title>Expression and regulation of neurotrophins in the nondegenerate and degenerate human intervertebral disc</article-title>. <source>Arthritis Res Ther</source>. (<year>2008</year>) <volume>10</volume>:<fpage>R99</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/ar2487</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Binch</surname> <given-names>AL</given-names>
</name>
<name>
<surname>Cole</surname> <given-names>AA</given-names>
</name>
<name>
<surname>Breakwell</surname> <given-names>LM</given-names>
</name>
<name>
<surname>Michael</surname> <given-names>AL</given-names>
</name>
<name>
<surname>Chiverton</surname> <given-names>N</given-names>
</name>
<name>
<surname>Cross</surname> <given-names>AK</given-names>
</name>
<etal/>
</person-group>. <article-title>Expression and regulation of neurotrophic and angiogenic factors during human intervertebral disc degeneration</article-title>. <source>Arthritis Res Ther</source>. (<year>2014</year>) <volume>16</volume>:<fpage>416</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13075-014-0416-1</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saxton</surname> <given-names>RA</given-names>
</name>
<name>
<surname>Glassman</surname> <given-names>CR</given-names>
</name>
<name>
<surname>Garcia</surname> <given-names>KC</given-names>
</name>
</person-group>. <article-title>Emerging principles of cytokine pharmacology and therapeutics</article-title>. <source>Nat Rev Drug Discovery</source>. (<year>2023</year>) <volume>22</volume>:<fpage>21</fpage>&#x2013;<lpage>37</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41573-022-00557-6</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leek</surname> <given-names>JT</given-names>
</name>
<name>
<surname>Johnson</surname> <given-names>WE</given-names>
</name>
<name>
<surname>Parker</surname> <given-names>HS</given-names>
</name>
<name>
<surname>Jaffe</surname> <given-names>AE</given-names>
</name>
<name>
<surname>Storey</surname> <given-names>JD</given-names>
</name>
</person-group>. <article-title>The sva package for removing batch effects and other unwanted variation in high-throughput experiments</article-title>. <source>Bioinf (Oxford England)</source>. (<year>2012</year>) <volume>28</volume>:<page-range>882&#x2013;3</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/bioinformatics/bts034</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Butler</surname> <given-names>A</given-names>
</name>
<name>
<surname>Hoffman</surname> <given-names>P</given-names>
</name>
<name>
<surname>Smibert</surname> <given-names>P</given-names>
</name>
<name>
<surname>Papalexi</surname> <given-names>E</given-names>
</name>
<name>
<surname>Satija</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Integrating single-cell transcriptomic data across different conditions, technologies, and species</article-title>. <source>Nat Biotechnol</source>. (<year>2018</year>) <volume>36</volume>:<page-range>411&#x2013;20</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nbt.4096</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Lv</surname> <given-names>X</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>X</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Fu</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>Integrated machine learning and single-sample gene set enrichment analysis identifies a TGF-beta signaling pathway derived score in headneck squamous cell carcinoma</article-title>. <source>J Oncol</source>. (<year>2022</year>) <volume>2022</volume>:<fpage>3140263</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2022/3140263</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cui</surname> <given-names>A</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>T</given-names>
</name>
<name>
<surname>Li</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>A</given-names>
</name>
<name>
<surname>P&#xe9;rez</surname> <given-names>JL</given-names>
</name>
<name>
<surname>Sander</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Dictionary of immune responses to cytokines at single-cell resolution</article-title>. <source>Nature</source>. (<year>2024</year>) <volume>625</volume>:<page-range>377&#x2013;84</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41586-023-06816-9</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Tian</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Sui</surname> <given-names>C</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Lai</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Single-cell transcriptomics of proliferative phase endometrium: systems analysis of cell-cell communication network using cellChat</article-title>. <source>Front Cell Dev Biol</source>. (<year>2022</year>) <volume>10</volume>:<elocation-id>919731</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcell.2022.919731</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ritchie</surname> <given-names>ME</given-names>
</name>
<name>
<surname>Phipson</surname> <given-names>B</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>D</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Law</surname> <given-names>CW</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>W</given-names>
</name>
<etal/>
</person-group>. <article-title>limma powers differential expression analyses for RNA-sequencing and microarray studies</article-title>. <source>Nucleic Acids Res</source>. (<year>2015</year>) <volume>43</volume>:<elocation-id>e47</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gkv007</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szklarczyk</surname> <given-names>D</given-names>
</name>
<name>
<surname>Gable</surname> <given-names>AL</given-names>
</name>
<name>
<surname>Nastou</surname> <given-names>KC</given-names>
</name>
<name>
<surname>Lyon</surname> <given-names>D</given-names>
</name>
<name>
<surname>Kirsch</surname> <given-names>R</given-names>
</name>
<name>
<surname>Pyysalo</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets</article-title>. <source>Nucleic Acids Res</source>. (<year>2021</year>) <volume>49</volume>:<fpage>D605</fpage>&#x2013;<lpage>d612</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gkaa1074</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shannon</surname> <given-names>P</given-names>
</name>
<name>
<surname>Markiel</surname> <given-names>A</given-names>
</name>
<name>
<surname>Ozier</surname> <given-names>O</given-names>
</name>
<name>
<surname>Baliga</surname> <given-names>NS</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>JT</given-names>
</name>
<name>
<surname>Ramage</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Cytoscape: a software environment for integrated models of biomolecular interaction networks</article-title>. <source>Genome Res</source>. (<year>2003</year>) <volume>13</volume>:<page-range>2498&#x2013;504</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1101/gr.1239303</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blake</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Christie</surname> <given-names>KR</given-names>
</name>
<name>
<surname>Dolan</surname> <given-names>ME</given-names>
</name>
<name>
<surname>Drabkin</surname> <given-names>HJ</given-names>
</name>
<name>
<surname>Hill</surname> <given-names>DP</given-names>
</name>
<name>
<surname>Ni</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Gene Ontology Consortium: going forward</article-title>. <source>Nucleic Acids Res</source>. (<year>2015</year>) <volume>43</volume>:<page-range>D1049&#x2013;56</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gku1179</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kanehisa</surname> <given-names>M</given-names>
</name>
<name>
<surname>Goto</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>KEGG: kyoto encyclopedia of genes and genomes</article-title>. <source>Nucleic Acids Res</source>. (<year>2000</year>) <volume>28</volume>:<fpage>27</fpage>&#x2013;<lpage>30</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/28.1.27</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname> <given-names>G</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>LG</given-names>
</name>
<name>
<surname>Han</surname> <given-names>Y</given-names>
</name>
<name>
<surname>He</surname> <given-names>QY</given-names>
</name>
</person-group>. <article-title>clusterProfiler: an R package for comparing biological themes among gene clusters</article-title>. <source>Omics: J Integr Biol</source>. (<year>2012</year>) <volume>16</volume>:<page-range>284&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1089/omi.2011.0118</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Warde-Farley</surname> <given-names>D</given-names>
</name>
<name>
<surname>Donaldson</surname> <given-names>SL</given-names>
</name>
<name>
<surname>Comes</surname> <given-names>O</given-names>
</name>
<name>
<surname>Zuberi</surname> <given-names>K</given-names>
</name>
<name>
<surname>Badrawi</surname> <given-names>R</given-names>
</name>
<name>
<surname>Chao</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function</article-title>. <source>Nucleic Acids Res</source>. (<year>2010</year>) <volume>38</volume>:<page-range>W214&#x2013;20</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gkq537</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname> <given-names>HY</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>YC</given-names>
</name>
<name>
<surname>Cui</surname> <given-names>S</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>miRTarBase update 2022: an informative resource for experimentally validated miRNA-target interactions</article-title>. <source>Nucleic Acids Res</source>. (<year>2022</year>) <volume>50</volume>:<fpage>D222</fpage>&#x2013;<lpage>d230</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gkab1079</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>JH</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>H</given-names>
</name>
<name>
<surname>Qu</surname> <given-names>LH</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>JH</given-names>
</name>
</person-group>. <article-title>starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data</article-title>. <source>Nucleic Acids Res</source>. (<year>2014</year>) <volume>42</volume>:<page-range>D92&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gkt1248</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiong</surname> <given-names>L</given-names>
</name>
<name>
<surname>Li</surname> <given-names>X</given-names>
</name>
<name>
<surname>Hua</surname> <given-names>X</given-names>
</name>
<name>
<surname>Qian</surname> <given-names>Z</given-names>
</name>
</person-group>. <article-title>Circ-STC2 promotes the ferroptosis of nucleus pulposus cells via targeting miR-486-3p/TFR2 axis</article-title>. <source>J Orthopaedic Surg Res</source>. (<year>2023</year>) <volume>18</volume>:<fpage>518</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13018-023-04010-1</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname> <given-names>B</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>K</given-names>
</name>
<name>
<surname>Li</surname> <given-names>FC</given-names>
</name>
<name>
<surname>Xiao</surname> <given-names>YX</given-names>
</name>
<name>
<surname>Feng</surname> <given-names>J</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>ZL</given-names>
</name>
<etal/>
</person-group>. <article-title>A simple disc degeneration model induced by percutaneous needle puncture in the rat tail</article-title>. <source>Spine (Phila Pa 1976)</source>. (<year>2008</year>) <volume>33</volume>:<page-range>1925&#x2013;34</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/BRS.0b013e31817c64a9</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alpantaki</surname> <given-names>K</given-names>
</name>
<name>
<surname>Zafiropoulos</surname> <given-names>A</given-names>
</name>
<name>
<surname>Tseliou</surname> <given-names>M</given-names>
</name>
<name>
<surname>Vasarmidi</surname> <given-names>E</given-names>
</name>
<name>
<surname>Sourvinos</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Herpes simplex virus type-1 infection affects the expression of extracellular matrix components in human nucleus pulposus cells</article-title>. <source>Virus Res</source>. (<year>2019</year>) <volume>259</volume>:<page-range>10&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.virusres.2018.10.010</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tripathi</surname> <given-names>PK</given-names>
</name>
<name>
<surname>Mittal</surname> <given-names>KR</given-names>
</name>
<name>
<surname>Jain</surname> <given-names>N</given-names>
</name>
<name>
<surname>Sharma</surname> <given-names>N</given-names>
</name>
<name>
<surname>Jain</surname> <given-names>CK</given-names>
</name>
</person-group>. <article-title>KRAS pathways: A potential gateway for cancer therapeutics and diagnostics</article-title>. <source>Recent Patents Anti-Cancer Drug Discovery</source>. (<year>2024</year>) <volume>19</volume>:<page-range>268&#x2013;79</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2174/1574892818666230406085120</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yi</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Niu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ji</surname> <given-names>G</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Lipid metabolism disorder promotes the development of intervertebral disc degeneration</article-title>. <source>Biomedicine Pharmacotherapy = Biomedecine pharmacotherapie</source>. (<year>2023</year>) <volume>166</volume>:<fpage>115401</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.biopha.2023.115401</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dou</surname> <given-names>X</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Luo</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Song</surname> <given-names>C</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>M</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>Therapeutic potential of melatonin in the intervertebral disc degeneration through inhibiting the ferroptosis of nucleus pulpous cells</article-title>. <source>J Cell Mol Med</source>. (<year>2023</year>) <volume>27</volume>:<page-range>2340&#x2013;53</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/jcmm.v27.16</pub-id>
</citation>
</ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Risbud</surname> <given-names>MV</given-names>
</name>
<name>
<surname>Shapiro</surname> <given-names>IM</given-names>
</name>
</person-group>. <article-title>Role of cytokines in intervertebral disc degeneration: pain and disc content</article-title>. <source>Nat Rev Rheumatol</source>. (<year>2014</year>) <volume>10</volume>:<fpage>44</fpage>&#x2013;<lpage>56</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrrheum.2013.160</pub-id>
</citation>
</ref>
<ref id="B44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taylor</surname> <given-names>VM</given-names>
</name>
<name>
<surname>Deyo</surname> <given-names>RA</given-names>
</name>
<name>
<surname>Cherkin</surname> <given-names>DC</given-names>
</name>
<name>
<surname>Kreuter</surname> <given-names>W</given-names>
</name>
</person-group>. <article-title>Low back pain hospitalization. Recent United States trends and regional variations</article-title>. <source>Spine</source>. (<year>1994</year>) <volume>19</volume>:<page-range>1207&#x2013;12</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/00007632-199405310-00002</pub-id>
</citation>
</ref>
<ref id="B45">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andersson</surname> <given-names>GB</given-names>
</name>
</person-group>. <article-title>Epidemiological features of chronic low-back pain</article-title>. <source>Lancet (London England)</source>. (<year>1999</year>) <volume>354</volume>:<page-range>581&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0140-6736(99)01312-4</pub-id>
</citation>
</ref>
<ref id="B46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Millecamps</surname> <given-names>M</given-names>
</name>
<name>
<surname>Czerminski</surname> <given-names>JT</given-names>
</name>
<name>
<surname>Mathieu</surname> <given-names>AP</given-names>
</name>
<name>
<surname>Stone</surname> <given-names>LS</given-names>
</name>
</person-group>. <article-title>Behavioral signs of axial low back pain and motor impairment correlate with the severity of intervertebral disc degeneration in a mouse model</article-title>. <source>Spine Journal: Off J North Am Spine Soc</source>. (<year>2015</year>) <volume>15</volume>:<page-range>2524&#x2013;37</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.spinee.2015.08.055</pub-id>
</citation>
</ref>
<ref id="B47">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bermudez-Lekerika</surname> <given-names>P</given-names>
</name>
<name>
<surname>Crump</surname> <given-names>KB</given-names>
</name>
<name>
<surname>Tseranidou</surname> <given-names>S</given-names>
</name>
<name>
<surname>N&#xfc;esch</surname> <given-names>A</given-names>
</name>
<name>
<surname>Kanelis</surname> <given-names>E</given-names>
</name>
<name>
<surname>Alminnawi</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Immuno-modulatory effects of intervertebral disc cells</article-title>. <source>Front Cell Dev Biol</source>. (<year>2022</year>) <volume>10</volume>:<elocation-id>924692</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcell.2022.924692</pub-id>
</citation>
</ref>
<ref id="B48">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ziegler-Heitbrock</surname> <given-names>L</given-names>
</name>
<name>
<surname>Ancuta</surname> <given-names>P</given-names>
</name>
<name>
<surname>Crowe</surname> <given-names>S</given-names>
</name>
<name>
<surname>Dalod</surname> <given-names>M</given-names>
</name>
<name>
<surname>Grau</surname> <given-names>V</given-names>
</name>
<name>
<surname>Hart</surname> <given-names>DN</given-names>
</name>
<etal/>
</person-group>. <article-title>Nomenclature of monocytes and dendritic cells in blood</article-title>. <source>Blood</source>. (<year>2010</year>) <volume>116</volume>:<page-range>e74&#x2013;80</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1182/blood-2010-02-258558</pub-id>
</citation>
</ref>
<ref id="B49">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>EG</given-names>
</name>
<name>
<surname>Yin</surname> <given-names>X</given-names>
</name>
<name>
<surname>Swaminathan</surname> <given-names>A</given-names>
</name>
<name>
<surname>Eisenbarth</surname> <given-names>SC</given-names>
</name>
</person-group>. <article-title>Antigen-presenting cells in food tolerance and allergy</article-title>. <source>Front Immunol</source>. (<year>2020</year>) <volume>11</volume>:<elocation-id>616020</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2020.616020</pub-id>
</citation>
</ref>
<ref id="B50">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname> <given-names>D</given-names>
</name>
<name>
<surname>Zeng</surname> <given-names>M</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>M</given-names>
</name>
<name>
<surname>Shang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>J</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>SSR1 and CKAP4 as potential biomarkers for intervertebral disc degeneration based on integrated bioinformatics analysis</article-title>. <source>JOR Spine</source>. (<year>2024</year>) <volume>7</volume>:<elocation-id>e1309</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/jsp2.1309</pub-id>
</citation>
</ref>
<ref id="B51">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kratofil</surname> <given-names>RM</given-names>
</name>
<name>
<surname>Kubes</surname> <given-names>P</given-names>
</name>
<name>
<surname>Deniset</surname> <given-names>JF</given-names>
</name>
</person-group>. <article-title>Monocyte conversion during inflammation and injury</article-title>. <source>Arteriosclerosis Thrombosis Vasc Biol</source>. (<year>2017</year>) <volume>37</volume>:<fpage>35</fpage>&#x2013;<lpage>42</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1161/ATVBAHA.116.308198</pub-id>
</citation>
</ref>
<ref id="B52">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>W</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>He</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Yuan</surname> <given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>Deciphering the sequential changes of monocytes/macrophages in the progression of IDD with longitudinal approach using single-cell transcriptome</article-title>. <source>Front Immunol</source>. (<year>2023</year>) <volume>14</volume>:<elocation-id>1090637</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2023.1090637</pub-id>
</citation>
</ref>
<ref id="B53">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cabral</surname> <given-names>VLF</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>F</given-names>
</name>
<name>
<surname>Peng</surname> <given-names>X</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Omentin-1 promoted proliferation and ameliorated inflammation, apoptosis, and degeneration in human nucleus pulposus cells</article-title>. <source>Arch Gerontology Geriatrics</source>. (<year>2022</year>) <volume>102</volume>:<fpage>104748</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.archger.2022.104748</pub-id>
</citation>
</ref>
<ref id="B54">
<label>54</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Dong</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Peng</surname> <given-names>R</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Song</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>Inhibition of IRE1 suppresses the catabolic effect of IL-1&#x3b2; on nucleus pulposus cell and prevents intervertebral disc degeneration <italic>in vivo</italic>
</article-title>. <source>Biochem Pharmacol</source>. (<year>2022</year>) <volume>197</volume>:<fpage>114932</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bcp.2022.114932</pub-id>
</citation>
</ref>
<ref id="B55">
<label>55</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>W</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Protective role of the alpha-1-antitrypsin in intervertebral disc degeneration</article-title>. <source>J Orthopaedic Surg Res</source>. (<year>2021</year>) <volume>16</volume>:<fpage>516</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13018-021-02668-z</pub-id>
</citation>
</ref>
<ref id="B56">
<label>56</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname> <given-names>JH</given-names>
</name>
<name>
<surname>Ham</surname> <given-names>CH</given-names>
</name>
<name>
<surname>Kwon</surname> <given-names>WK</given-names>
</name>
</person-group>. <article-title>Current knowledge and future therapeutic prospects in symptomatic intervertebral disc degeneration</article-title>. <source>Yonsei Med J</source>. (<year>2022</year>) <volume>63</volume>:<fpage>199</fpage>&#x2013;<lpage>210</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3349/ymj.2022.63.3.199</pub-id>
</citation>
</ref>
<ref id="B57">
<label>57</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meyer</surname> <given-names>O</given-names>
</name>
</person-group>. <article-title>Interferons and autoimmune disorders</article-title>. <source>Joint Bone Spine</source>. (<year>2009</year>) <volume>76</volume>:<page-range>464&#x2013;73</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jbspin.2009.03.012</pub-id>
</citation>
</ref>
<ref id="B58">
<label>58</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ji</surname> <given-names>L</given-names>
</name>
<name>
<surname>Li</surname> <given-names>T</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>H</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>E</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>The crucial regulatory role of type I interferon in inflammatory diseases</article-title>. <source>Cell Bioscience</source>. (<year>2023</year>) <volume>13</volume>:<fpage>230</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13578-023-01188-z</pub-id>
</citation>
</ref>
<ref id="B59">
<label>59</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McNab</surname> <given-names>F</given-names>
</name>
<name>
<surname>Mayer-Barber</surname> <given-names>K</given-names>
</name>
<name>
<surname>Sher</surname> <given-names>A</given-names>
</name>
<name>
<surname>Wack</surname> <given-names>A</given-names>
</name>
<name>
<surname>O&#x2019;Garra</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Type I interferons in infectious disease</article-title>. <source>Nat Rev Immunol</source>. (<year>2015</year>) <volume>15</volume>:<fpage>87</fpage>&#x2013;<lpage>103</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nri3787</pub-id>
</citation>
</ref>
<ref id="B60">
<label>60</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schreiber</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>The role of type I interferons in the pathogenesis and treatment of COVID-19</article-title>. <source>Front Immunol</source>. (<year>2020</year>) <volume>11</volume>:<elocation-id>595739</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2020.595739</pub-id>
</citation>
</ref>
<ref id="B61">
<label>61</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gerke</surname> <given-names>V</given-names>
</name>
<name>
<surname>Gavins</surname> <given-names>FNE</given-names>
</name>
<name>
<surname>Geisow</surname> <given-names>M</given-names>
</name>
<name>
<surname>Grewal</surname> <given-names>T</given-names>
</name>
<name>
<surname>Jaiswal</surname> <given-names>JK</given-names>
</name>
<name>
<surname>Nylandsted</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Annexins-a family of proteins with distinctive tastes for cell signaling and membrane dynamics</article-title>. <source>Nat Commun</source>. (<year>2024</year>) <volume>15</volume>:<fpage>1574</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41467-024-45954-0</pub-id>
</citation>
</ref>
<ref id="B62">
<label>62</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jia</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Kang</surname> <given-names>B</given-names>
</name>
<name>
<surname>Dong</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Fan</surname> <given-names>M</given-names>
</name>
<name>
<surname>Li</surname> <given-names>W</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>W</given-names>
</name>
</person-group>. <article-title>Annexin A5 derived from cell-free fat extract attenuates osteoarthritis via macrophage regulation</article-title>. <source>Int J Biol Sci</source>. (<year>2024</year>) <volume>20</volume>:<fpage>2994</fpage>&#x2013;<lpage>3007</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.7150/ijbs.92802</pub-id>
</citation>
</ref>
<ref id="B63">
<label>63</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>You</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Ke</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>X</given-names>
</name>
<name>
<surname>Yan</surname> <given-names>W</given-names>
</name>
<name>
<surname>Li</surname> <given-names>D</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Loss of endothelial annexin A1 aggravates inflammation-induched vascular aging</article-title>. <source>Advanced Sci (Weinheim Baden-Wurttemberg Germany)</source>. (<year>2024</year>) <volume>11</volume>:<elocation-id>e2307040</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/advs.202307040</pub-id>
</citation>
</ref>
<ref id="B64">
<label>64</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vago</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Nogueira</surname> <given-names>CR</given-names>
</name>
<name>
<surname>Tavares</surname> <given-names>LP</given-names>
</name>
<name>
<surname>Soriani</surname> <given-names>FM</given-names>
</name>
<name>
<surname>Lopes</surname> <given-names>F</given-names>
</name>
<name>
<surname>Russo</surname> <given-names>RC</given-names>
</name>
<etal/>
</person-group>. <article-title>Annexin A1 modulates natural and glucocorticoid-induced resolution of inflammation by enhancing neutrophil apoptosis</article-title>. <source>J Leukocyte Biol</source>. (<year>2012</year>) <volume>92</volume>:<page-range>249&#x2013;58</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1189/jlb.0112008</pub-id>
</citation>
</ref>
<ref id="B65">
<label>65</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scannell</surname> <given-names>M</given-names>
</name>
<name>
<surname>Flanagan</surname> <given-names>MB</given-names>
</name>
<name>
<surname>deStefani</surname> <given-names>A</given-names>
</name>
<name>
<surname>Wynne</surname> <given-names>KJ</given-names>
</name>
<name>
<surname>Cagney</surname> <given-names>G</given-names>
</name>
<name>
<surname>Godson</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Annexin-1 and peptide derivatives are released by apoptotic cells and stimulate phagocytosis of apoptotic neutrophils by macrophages</article-title>. <source>J Immunol</source>. (<year>2007</year>) <volume>178</volume>:<page-range>4595&#x2013;605</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.178.7.4595</pub-id>
</citation>
</ref>
<ref id="B66">
<label>66</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shao</surname> <given-names>T</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>W</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Gu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>Z</given-names>
</name>
</person-group>. <article-title>The role of immunocyte infiltration regulatory network based on hdWGCNA and single-cell bioinformatics analysis in intervertebral disc degeneration</article-title>. <source>Inflammation</source>. (<year>2024</year>). doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s10753-024-02020-7</pub-id>
</citation>
</ref>
<ref id="B67">
<label>67</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiang</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>J</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Li</surname> <given-names>W</given-names>
</name>
</person-group>. <article-title>The Nrf2 antioxidant defense system in intervertebral disc degeneration: Molecular insights</article-title>. <source>Exp Mol Med</source>. (<year>2022</year>) <volume>54</volume>:<page-range>1067&#x2013;75</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s12276-022-00829-6</pub-id>
</citation>
</ref>
<ref id="B68">
<label>68</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiao</surname> <given-names>L</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>SJ</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>C</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>B</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>HG</given-names>
</name>
</person-group>. <article-title>Sod2 and catalase improve pathological conditions of intervertebral disc degeneration by modifying human adipose-derived mesenchymal stem cells</article-title>. <source>Life Sci</source>. (<year>2021</year>) <volume>267</volume>:<fpage>118929</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.lfs.2020.118929</pub-id>
</citation>
</ref>
<ref id="B69">
<label>69</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Honda</surname> <given-names>K</given-names>
</name>
<name>
<surname>Yanai</surname> <given-names>H</given-names>
</name>
<name>
<surname>Negishi</surname> <given-names>H</given-names>
</name>
<name>
<surname>Asagiri</surname> <given-names>M</given-names>
</name>
<name>
<surname>Sato</surname> <given-names>M</given-names>
</name>
<name>
<surname>Mizutani</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>IRF-7 is the master regulator of type-I interferon-dependent immune responses</article-title>. <source>Nature</source>. (<year>2005</year>) <volume>434</volume>:<page-range>772&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nature03464</pub-id>
</citation>
</ref>
<ref id="B70">
<label>70</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mari&#xe9;</surname> <given-names>I</given-names>
</name>
<name>
<surname>Durbin</surname> <given-names>JE</given-names>
</name>
<name>
<surname>Levy</surname> <given-names>DE</given-names>
</name>
</person-group>. <article-title>Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7</article-title>. <source>EMBO J</source>. (<year>1998</year>) <volume>17</volume>:<page-range>6660&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/emboj/17.22.6660</pub-id>
</citation>
</ref>
<ref id="B71">
<label>71</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sato</surname> <given-names>M</given-names>
</name>
<name>
<surname>Hata</surname> <given-names>N</given-names>
</name>
<name>
<surname>Asagiri</surname> <given-names>M</given-names>
</name>
<name>
<surname>Nakaya</surname> <given-names>T</given-names>
</name>
<name>
<surname>Taniguchi</surname> <given-names>T</given-names>
</name>
<name>
<surname>Tanaka</surname> <given-names>N</given-names>
</name>
</person-group>. <article-title>Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7</article-title>. <source>FEBS Lett</source>. (<year>1998</year>) <volume>441</volume>:<page-range>106&#x2013;10</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0014-5793(98)01514-2</pub-id>
</citation>
</ref>
<ref id="B72">
<label>72</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koroth</surname> <given-names>J</given-names>
</name>
<name>
<surname>Buko</surname> <given-names>EO</given-names>
</name>
<name>
<surname>Abbott</surname> <given-names>R</given-names>
</name>
<name>
<surname>Johnson</surname> <given-names>CP</given-names>
</name>
<name>
<surname>Ogle</surname> <given-names>BM</given-names>
</name>
<name>
<surname>Stone</surname> <given-names>LS</given-names>
</name>
<etal/>
</person-group>. <article-title>Macrophages and intervertebral disc degeneration</article-title>. <source>Int J Mol Sci</source>. (<year>2023</year>) <volume>24</volume>:<elocation-id>1367</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms24021367</pub-id>
</citation>
</ref>
<ref id="B73">
<label>73</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>L</given-names>
</name>
<name>
<surname>Dai</surname> <given-names>M</given-names>
</name>
<name>
<surname>Zuo</surname> <given-names>W</given-names>
</name>
<name>
<surname>Dai</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>NF-&#x3ba;B p65 and SETDB1 expedite lipopolysaccharide-induced intestinal inflammation in mice by inducing IRF7/NLR-dependent macrophage M1 polarization</article-title>. <source>Int Immunopharmacol</source>. (<year>2023</year>) <volume>115</volume>:<fpage>109554</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.intimp.2022.109554</pub-id>
</citation>
</ref>
<ref id="B74">
<label>74</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname> <given-names>J</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Xiao</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Lei</surname> <given-names>A</given-names>
</name>
<name>
<surname>Li</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>IRF-7 is a critical regulator of type 2 innate lymphoid cells in allergic airway inflammation</article-title>. <source>Cell Rep</source>. (<year>2019</year>) <volume>29</volume>:<fpage>2718</fpage>&#x2013;<lpage>2730.e6</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.celrep.2019.10.077</pub-id>
</citation>
</ref>
<ref id="B75">
<label>75</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Lavorgna</surname> <given-names>A</given-names>
</name>
<name>
<surname>Bowman</surname> <given-names>M</given-names>
</name>
<name>
<surname>Hiscott</surname> <given-names>J</given-names>
</name>
<name>
<surname>Harhaj</surname> <given-names>EW</given-names>
</name>
</person-group>. <article-title>Aryl hydrocarbon receptor interacting protein targets IRF7 to suppress antiviral signaling and the induction of type I interferon</article-title>. <source>J Biol Chem</source>. (<year>2015</year>) <volume>290</volume>:<page-range>14729&#x2013;39</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M114.633065</pub-id>
</citation>
</ref>
</ref-list>
<glossary>
<title>Glossary</title>
<def-list>
<def-item>
<term>IDD</term>
<def>
<p>Intervertebral disc degeneration</p>
</def>
</def-item>
<def-item>
<term>LBP</term>
<def>
<p>low back pain</p>
</def>
</def-item>
<def-item>
<term>AF</term>
<def>
<p>Annulus fibrosus</p>
</def>
</def-item>
<def-item>
<term>NP</term>
<def>
<p>Nucleus pulposus</p>
</def>
</def-item>
<def-item>
<term>CEP</term>
<def>
<p>Cartilaginous endplate</p>
</def>
</def-item>
<def-item>
<term>NPC</term>
<def>
<p>Nucleus pulposus cell</p>
</def>
</def-item>
<def-item>
<term>GEO</term>
<def>
<p>Gene Expression Omnibus</p>
</def>
</def-item>
<def-item>
<term>PCA</term>
<def>
<p>Principal component analysis</p>
</def>
</def-item>
<def-item>
<term>PC</term>
<def>
<p>Principal component</p>
</def>
</def-item>
<def-item>
<term>SNN</term>
<def>
<p>Shared Nearest Neighbor</p>
</def>
</def-item>
<def-item>
<term>t-SNE</term>
<def>
<p>t-distributed stochastic neighbour embedding</p>
</def>
</def-item>
<def-item>
<term>ssGSEA</term>
<def>
<p>Single sample gene set enrichment analysis</p>
</def>
</def-item>
<def-item>
<term>GSEA</term>
<def>
<p>Gene set enrichment analysis</p>
</def>
</def-item>
<def-item>
<term>SVM-RFE</term>
<def>
<p>Support Vector Machine-Recursive Feature Elimination</p>
</def>
</def-item>
<def-item>
<term>MDA</term>
<def>
<p>Mean decrease accuracy</p>
</def>
</def-item>
<def-item>
<term>MDG</term>
<def>
<p>Mean decrease Gini</p>
</def>
</def-item>
<def-item>
<term>IREA</term>
<def>
<p>Immune Response Enrichment Analysis</p>
</def>
</def-item>
<def-item>
<term>DEG</term>
<def>
<p>Differentially expressed genes</p>
</def>
</def-item>
<def-item>
<term>PPI</term>
<def>
<p>Protein-protein Interaction</p>
</def>
</def-item>
<def-item>
<term>STRING</term>
<def>
<p>Search Tool for the Retrieval of Interacting Genes</p>
</def>
</def-item>
<def-item>
<term>GO</term>
<def>
<p>Gene Ontology</p>
</def>
</def-item>
<def-item>
<term>KEGG</term>
<def>
<p>Kyoto Encyclopedia of Genes and Genomes</p>
</def>
</def-item>
<def-item>
<term>BP</term>
<def>
<p>Biological Process</p>
</def>
</def-item>
<def-item>
<term>MF</term>
<def>
<p>Molecular Function</p>
</def>
</def-item>
<def-item>
<term>CC</term>
<def>
<p>Cellular Component</p>
</def>
</def-item>
<def-item>
<term>ceRNA</term>
<def>
<p>Competing endogenous RNA</p>
</def>
</def-item>
<def-item>
<term>RBP</term>
<def>
<p>RNA-binding protein</p>
</def>
</def-item>
<def-item>
<term>TRRUST</term>
<def>
<p>Transcription Regulatory Relationships Unraveled Sentence-based Text Mining</p>
</def>
</def-item>
<def-item>
<term>FBS</term>
<def>
<p>Fetal bovine serum</p>
</def>
</def-item>
<def-item>
<term>siRNA</term>
<def>
<p>Small interfering RNA</p>
</def>
</def-item>
<def-item>
<term>SD</term>
<def>
<p>Sprague-Dawley</p>
</def>
</def-item>
<def-item>
<term>MRI</term>
<def>
<p>Magnetic resonance imaging</p>
</def>
</def-item>
<def-item>
<term>DHI</term>
<def>
<p>Disc height index</p>
</def>
</def-item>
<def-item>
<term>HE</term>
<def>
<p>Hematoxylin-eosin</p>
</def>
</def-item>
<def-item>
<term>SO&amp;FG</term>
<def>
<p>Safranin O-Fast Green</p>
</def>
</def-item>
<def-item>
<term>BSA</term>
<def>
<p>Bovine serum albumin</p>
</def>
</def-item>
<def-item>
<term>Pro_NP</term>
<def>
<p>Progenitor nucleus pulposus</p>
</def>
</def-item>
<def-item>
<term>GSVA</term>
<def>
<p>Gene Set Variation Analysis</p>
</def>
</def-item>
<def-item>
<term>TF</term>
<def>
<p>Transcription factor</p>
</def>
</def-item>
<def-item>
<term>ECM</term>
<def>
<p>Extracellular matrix</p>
</def>
</def-item>
<def-item>
<term>CMAP</term>
<def>
<p>Connectivity Map</p>
</def>
</def-item>
<def-item>
<term>APC</term>
<def>
<p>Antigen-presenting cell</p>
</def>
</def-item>
<def-item>
<term>MMP</term>
<def>
<p>Matrix metalloproteinase</p>
</def>
</def-item>
<def-item>
<term>GC</term>
<def>
<p>Glucocorticoid</p>
</def>
</def-item>
<def-item>
<term>POLR2A</term>
<def>
<p>RNA polymerase II subunit A</p>
</def>
</def-item>
<def-item>
<term>IRF7</term>
<def>
<p>Interferon regulatory factor 7;NLR, Nod-like receptor</p>
</def>
</def-item>
<def-item>
<term>AIP</term>
<def>
<p>Aryl Hydrocarbon Receptor Interacting Protein.</p>
</def>
</def-item>
<def-item>
<term>UMAP</term>
<def>
<p>Uniform Manifold Approximation and Projection</p>
</def>
</def-item>
<def-item>
<term>NLR</term>
<def>
<p>Nod-like receptor</p>
</def>
</def-item>
</def-list>
</glossary>
</back>
</article>